The	O	DET	O
adenomatous	B-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
coli	I-Disease	X	I
(	I-Disease	PUNCT	O
APC	I-Disease	NOUN	B
)	I-Disease	PUNCT	O
tumour	I-Disease	NOUN	B
-	O	PUNCT	O
suppressor	O	NOUN	B
protein	O	NOUN	I
controls	O	VERB	O
the	O	DET	O
Wnt	O	NOUN	B
signalling	O	NOUN	I
pathway	O	NOUN	I
by	O	ADP	O
forming	O	VERB	O
a	O	DET	O
complex	O	NOUN	B
with	O	ADP	O
glycogen	O	NOUN	B
synthase	O	NOUN	I
kinase	O	NOUN	I
3beta	O	NOUN	I
(	O	PUNCT	O
GSK	O	PROPN	B
-	O	PUNCT	O
3beta	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
axin	O	NOUN	B
/	O	SYM	O
conductin	O	NOUN	B
and	O	CCONJ	O
betacatenin	O	NOUN	B
.	O	PUNCT	O


Like	O	ADP	O
APC	O	NOUN	B
,	O	PUNCT	O
APC2	O	NOUN	B
regulates	O	VERB	B
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
active	O	ADJ	O
betacatenin	O	NOUN	B
-	O	PUNCT	O
Tcf	O	NOUN	B
complexes	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
demonstrated	O	VERB	O
using	O	VERB	O
transient	O	ADJ	B
transcriptional	O	ADJ	O
activation	O	NOUN	O
assays	O	NOUN	O
in	O	ADP	O
APC	O	NOUN	B
-	O	PUNCT	O
/	O	SYM	B
-	O	PUNCT	O
colon	B-Disease	NOUN	B
carcinoma	I-Disease	NOUN	I
cells	O	NOUN	O
.	O	PUNCT	O


A	O	DET	O
common	O	ADJ	O
MSH2	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
English	O	PROPN	B
and	O	CCONJ	O
North	O	ADJ	B
American	O	ADJ	I
HNPCC	B-Disease	NOUN	B
families	O	NOUN	B
:	O	PUNCT	O
origin	O	NOUN	B
,	O	PUNCT	O
phenotypic	O	ADJ	B
expression	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
sex	O	NOUN	B
specific	O	ADJ	O
differences	O	NOUN	O
in	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
frequency	O	NOUN	B
,	O	PUNCT	O
origin	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
phenotypic	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
germline	O	NOUN	B
MSH2	O	NOUN	I
gene	O	NOUN	B
mutation	O	NOUN	I
previously	O	ADV	O
identified	O	VERB	B
in	O	ADP	O
seven	O	NUM	O
kindreds	O	NOUN	B
with	O	ADP	O
hereditary	B-Disease	ADJ	B
non	I-Disease	ADJ	B
-	I-Disease	PUNCT	O
polyposis	I-Disease	NOUN	B
cancer	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
HNPCC	B-Disease	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
investigated	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
MSH2	O	NOUN	B
mutation	O	NOUN	B
was	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
10	O	NUM	O
of	O	ADP	O
20	O	NUM	O
(	O	PUNCT	O
50	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
separately	O	ADV	O
identified	O	VERB	B
colorectal	B-Disease	ADJ	B
families	O	NOUN	I
from	O	ADP	O
Newfoundland	O	PROPN	B
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggested	O	VERB	O
a	O	DET	O
founder	O	NOUN	B
effect	O	NOUN	B
within	O	ADP	O
Newfoundland	O	NOUN	B
similar	O	ADJ	O
to	O	ADP	O
that	O	DET	O
reported	O	VERB	O
by	O	ADP	O
others	O	NOUN	O
for	O	ADP	O
two	O	NUM	O
MLH1	O	NOUN	B
mutations	O	NOUN	B
in	O	ADP	O
Finnish	O	ADJ	B
HNPCC	B-Disease	NOUN	B
families	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
was	O	AUX	O
significantly	O	ADV	B
higher	O	ADJ	I
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
)	O	PUNCT	O
in	O	ADP	O
males	O	NOUN	B
than	O	ADP	O
females	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
63	O	NUM	O
v	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
30	O	NUM	O
and	O	CCONJ	O
0	O	NUM	O
.	O	PUNCT	O
84	O	NUM	O
v	O	PART	O
0	O	NUM	O
.	O	PUNCT	O
44	O	NUM	O
at	O	ADP	O
ages	O	NOUN	B
50	O	NUM	O
and	O	CCONJ	O
60	O	NUM	O
years	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


For	O	ADP	O
females	O	NOUN	B
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
high	O	ADJ	O
risk	O	NOUN	B
of	O	ADP	O
endometrial	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
at	O	ADP	O
age	O	NOUN	B
60	O	NUM	O
years	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
premenopausal	B-Disease	ADJ	B
ovarian	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
2	O	NUM	O
at	O	ADP	O
50	O	NUM	O
years	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Age	O	NOUN	B
of	O	ADP	O
onset	O	NOUN	O
(	O	PUNCT	O
AO	O	NOUN	B
)	O	PUNCT	O
of	O	ADP	O
Huntington	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
HD	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
be	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
length	O	NOUN	B
of	O	ADP	O
an	O	DET	O
expanded	O	VERB	O
CAG	O	NOUN	B
repeat	O	NOUN	I
in	O	ADP	O
the	O	DET	O
HD	B-Disease	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Apolipoprotein	O	NOUN	B
E	O	NOUN	I
(	O	PUNCT	O
APOE	O	NOUN	B
)	O	PUNCT	O
genotype	O	NOUN	B
,	O	PUNCT	O
in	O	ADP	O
turn	O	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
influence	O	VERB	B
AO	O	PROPN	B
in	O	ADP	O
Alzheimer	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
,	O	PUNCT	O
rendering	O	VERB	O
the	O	DET	O
APOE	O	NOUN	B
gene	O	NOUN	I
a	O	DET	O
likely	O	ADJ	O
candidate	O	NOUN	O
to	O	PART	O
affect	O	VERB	O
AO	O	PROPN	B
in	O	ADP	O
other	O	ADJ	O
neurological	B-Disease	ADJ	B
diseases	I-Disease	NOUN	I
too	O	ADV	O
.	O	PUNCT	O


Our	O	PRON	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
subtle	O	ADJ	O
differences	O	NOUN	B
in	O	ADP	O
the	O	DET	O
course	O	NOUN	B
of	O	ADP	O
the	O	DET	O
neurodegeneration	B-Disease	NOUN	B
in	O	ADP	O
HD	B-Disease	NOUN	B
may	O	AUX	O
allow	O	VERB	O
interacting	O	VERB	B
genes	O	NOUN	I
to	O	PART	O
exert	O	VERB	O
gender	O	NOUN	B
specific	O	ADJ	O
effects	O	NOUN	B
upon	O	SCONJ	O
AO	O	PROPN	B
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
deficiency	I-Disease	NOUN	I
of	I-Disease	ADP	O
the	I-Disease	DET	O
seventh	I-Disease	ADJ	O
component	I-Disease	NOUN	O
of	I-Disease	ADP	O
complement	I-Disease	NOUN	O
associated	O	VERB	B
with	O	ADP	I
recurrent	O	ADJ	B
bacteremic	B-Disease	ADJ	B
infections	I-Disease	NOUN	I
due	I-Disease	ADJ	O
to	I-Disease	PART	O
Neisseria	I-Disease	PROPN	B
.	O	PUNCT	O


The	O	DET	O
absence	B-Disease	NOUN	B
of	I-Disease	ADP	O
functional	I-Disease	ADJ	B
C7	I-Disease	NOUN	B
activity	O	NOUN	I
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
accounted	O	VERB	O
for	O	ADP	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
an	O	DET	O
inhibitor	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
report	O	NOUN	B
represents	O	VERB	O
the	O	DET	O
first	O	ADJ	O
cases	O	NOUN	B
of	O	ADP	O
C7	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
associated	O	VERB	B
with	O	ADP	I
infectious	O	ADJ	B
complications	O	NOUN	I
and	O	CCONJ	O
suggests	O	VERB	O
that	O	SCONJ	O
bactericidal	O	ADJ	B
activity	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
important	O	ADJ	O
in	O	ADP	O
host	O	NOUN	B
defense	O	NOUN	B
against	O	ADP	O
bacteremic	B-Disease	ADJ	B
neisseria	I-Disease	NOUN	O
infections	I-Disease	NOUN	O
.	O	PUNCT	O


OBJECTIVE	O	VERB	O
Previous	O	ADJ	O
reports	O	NOUN	B
have	O	AUX	O
suggested	O	VERB	O
an	O	DET	O
increased	O	VERB	B
risk	O	NOUN	B
of	O	ADP	O
cancer	B-Disease	NOUN	B
among	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
cartilage	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
hair	I-Disease	NOUN	B
hypoplasia	I-Disease	NOUN	I
(	O	PUNCT	O
CHH	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


This	O	DET	O
study	O	NOUN	B
was	O	AUX	O
carried	O	VERB	O
out	O	ADP	O
to	O	PART	O
further	O	ADV	O
evaluate	O	VERB	B
this	O	DET	O
risk	O	NOUN	B
among	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
CHH	B-Disease	NOUN	B
and	O	CCONJ	O
their	O	PRON	O
first	O	ADJ	B
-	O	PUNCT	O
degree	O	NOUN	B
relatives	O	NOUN	O
.	O	PUNCT	O


This	O	DET	O
cohort	O	NOUN	B
underwent	O	VERB	O
follow	O	VERB	B
-	O	PUNCT	O
up	O	NOUN	O
for	O	ADP	O
cancer	B-Disease	NOUN	B
incidence	O	NOUN	B
through	O	ADP	O
the	O	DET	O
Finnish	O	PROPN	B
Cancer	O	PROPN	I
Registry	O	PROPN	I
to	O	ADP	O
the	O	DET	O
end	O	NOUN	O
of	O	ADP	O
1995	O	NUM	O
.	O	PUNCT	O


The	O	DET	O
cancer	B-Disease	NOUN	B
incidence	O	NOUN	B
among	O	ADP	O
the	O	DET	O
siblings	O	NOUN	B
or	O	CCONJ	O
the	O	DET	O
parents	O	NOUN	B
did	O	AUX	O
not	O	PART	O
differ	O	VERB	O
from	O	ADP	O
the	O	DET	O
average	O	ADJ	B
cancer	B-Disease	NOUN	B
incidence	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Finnish	O	ADJ	B
population	O	NOUN	B
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
This	O	DET	O
study	O	NOUN	B
confirms	O	VERB	O
an	O	DET	O
increased	O	VERB	B
risk	O	NOUN	B
of	O	ADP	O
cancer	B-Disease	NOUN	B
,	O	PUNCT	O
especially	O	ADV	O
non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
Hodgkins	I-Disease	NOUN	B
lymphoma	I-Disease	NOUN	I
,	O	PUNCT	O
probably	O	ADV	O
attributable	O	ADJ	O
to	O	PART	O
defective	O	ADJ	B
immunity	O	NOUN	B
,	O	PUNCT	O
among	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
CHH	B-Disease	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
order	O	NOUN	O
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
genetic	O	ADJ	B
and	O	CCONJ	O
phenotypic	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
DPD	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
reviewed	O	VERB	B
17	O	NUM	O
families	O	NOUN	B
presenting	O	VERB	O
22	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
complete	O	ADJ	O
deficiency	B-Disease	NOUN	B
of	I-Disease	ADP	O
DPD	I-Disease	NOUN	B
.	O	PUNCT	O


A	O	DET	O
large	O	ADJ	O
phenotypic	O	ADJ	B
variability	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
observed	O	VERB	B
,	O	PUNCT	O
with	O	ADP	O
convulsive	B-Disease	ADJ	B
disorders	I-Disease	NOUN	I
,	O	PUNCT	O
motor	B-Disease	NOUN	B
retardation	I-Disease	NOUN	I
and	O	CCONJ	O
mental	B-Disease	ADJ	B
retardation	I-Disease	NOUN	I
being	O	AUX	O
the	O	DET	O
most	O	ADV	O
abundant	O	ADJ	B
manifestations	O	NOUN	B
.	O	PUNCT	O


An	O	DET	O
altered	O	ADJ	O
beta	O	NOUN	B
-	O	PUNCT	O
alanine	O	NOUN	B
,	O	PUNCT	O
uracil	O	NOUN	B
and	O	CCONJ	O
thymine	O	NOUN	B
homeostasis	O	NOUN	B
might	O	AUX	O
underlie	O	VERB	O
the	O	DET	O
various	O	ADJ	O
clinical	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
encountered	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
DPD	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
identified	O	VERB	O
a	O	DET	O
male	O	ADJ	B
patient	O	NOUN	B
with	O	ADP	O
BFLS	B-Disease	NOUN	B
-	O	PUNCT	O
like	O	ADJ	B
features	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
duplication	O	NOUN	B
,	O	PUNCT	O
46	O	NUM	O
,	O	PUNCT	O
Y	O	NOUN	B
,	O	PUNCT	O
dup	O	NOUN	O
(	O	PUNCT	O
X	O	NOUN	O
)	O	PUNCT	O
(	O	PUNCT	O
q26q28	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
inherited	O	VERB	B
from	O	ADP	O
his	O	PRON	O
phenotypically	O	ADV	B
normal	O	ADJ	I
mother	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
FHF2	O	NOUN	B
gene	O	NOUN	B
localisation	O	NOUN	I
and	O	CCONJ	O
tissue	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
expression	O	NOUN	B
pattern	O	NOUN	O
suggest	O	VERB	O
it	O	PRON	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
candidate	O	NOUN	O
gene	O	NOUN	B
for	O	ADP	O
familial	O	ADJ	B
cases	O	NOUN	I
of	O	ADP	O
the	O	DET	O
BFLS	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
and	O	CCONJ	O
other	O	ADJ	O
syndromal	O	ADJ	B
and	O	CCONJ	O
non	O	ADJ	B
-	O	PUNCT	O
specific	O	ADJ	B
forms	O	NOUN	O
of	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
mental	I-Disease	ADJ	B
retardation	I-Disease	NOUN	I
mapping	O	NOUN	O
to	O	PART	O
the	O	DET	O
region	O	NOUN	B
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
gastric	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
is	O	AUX	O
genetically	O	ADV	B
heterogeneous	O	ADJ	I
and	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
not	O	PART	O
clear	O	ADJ	O
what	O	DET	O
proportion	O	NOUN	B
of	O	ADP	O
gastric	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
susceptibility	O	NOUN	B
in	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
Maori	O	PROPN	B
populations	O	NOUN	B
is	O	AUX	O
due	O	ADJ	O
to	O	PART	O
germline	O	NOUN	B
CDH1	O	NOUN	B
mutations	O	NOUN	B
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
screened	O	VERB	B
eight	O	NUM	O
familial	B-Disease	ADJ	B
gastric	I-Disease	ADJ	I
cancer	I-Disease	NOUN	I
kindreds	O	NOUN	B
of	O	ADP	O
British	O	ADJ	B
and	O	CCONJ	O
Irish	O	ADJ	B
origin	O	NOUN	B
for	O	ADP	O
germline	O	NOUN	B
CDH1	O	NOUN	B
mutations	O	NOUN	B
,	O	PUNCT	O
by	O	ADP	O
SSCP	O	NOUN	B
analysis	O	NOUN	B
of	O	ADP	O
all	O	DET	O
16	O	NUM	O
exons	O	NOUN	B
and	O	CCONJ	O
flanking	O	ADJ	O
sequences	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
one	O	NUM	O
family	O	NOUN	B
there	O	PRON	O
was	O	AUX	O
evidence	O	NOUN	B
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
penetrance	O	NOUN	B
and	O	CCONJ	O
susceptibility	O	NOUN	B
to	O	PART	O
both	O	CCONJ	O
gastric	B-Disease	ADJ	B
and	I-Disease	CCONJ	O
colorectal	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
;	O	PUNCT	O
thus	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
addition	O	NOUN	O
to	O	ADP	O
six	O	NUM	O
cases	O	NOUN	B
of	O	ADP	O
gastric	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
,	O	PUNCT	O
a	O	DET	O
CDH1	O	NOUN	B
mutation	O	NOUN	B
carrier	O	NOUN	I
developed	O	VERB	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
at	O	ADP	O
age	O	NOUN	B
30	O	NUM	O
years	O	NOUN	B
.	O	PUNCT	O


Loss	O	NOUN	B
of	O	ADP	O
E	O	PROPN	B
-	O	PUNCT	O
cadherin	O	NOUN	B
function	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
implicated	O	VERB	O
in	O	ADP	O
the	O	DET	O
pathogenesis	O	NOUN	B
of	O	ADP	O
sporadic	O	ADJ	B
colorectal	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
other	I-Disease	ADJ	O
cancers	I-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
our	O	PRON	O
findings	O	NOUN	B
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
germline	O	NOUN	B
CDH1	O	NOUN	B
mutations	O	NOUN	B
predispose	O	VERB	O
to	O	PART	O
early	O	ADJ	B
onset	O	NOUN	O
colorectal	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
CDH1	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
investigated	O	VERB	B
as	O	ADP	O
a	O	DET	O
cause	O	NOUN	O
of	O	ADP	O
inherited	O	VERB	B
susceptibility	O	NOUN	B
to	O	PART	O
both	O	CCONJ	O
gastric	B-Disease	ADJ	B
and	I-Disease	CCONJ	O
colorectal	I-Disease	ADJ	B
cancers	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
diseases	O	NOUN	B
linked	O	VERB	O
specifically	O	ADV	O
with	O	ADP	O
WT1	O	NOUN	B
mutations	O	NOUN	B
,	O	PUNCT	O
such	O	ADJ	O
as	O	ADP	O
Denys	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Drash	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
DDS	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
can	O	AUX	O
provide	O	VERB	O
valuable	O	ADJ	O
insight	O	NOUN	O
concerning	O	VERB	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
WT1	O	NOUN	B
in	O	ADP	O
development	O	NOUN	B
and	O	CCONJ	O
disease	O	NOUN	B
.	O	PUNCT	O


DDS	B-Disease	NOUN	B
is	O	AUX	O
a	O	DET	O
rare	O	ADJ	B
childhood	O	NOUN	B
disease	O	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
a	O	DET	O
nephropathy	B-Disease	NOUN	B
involving	O	VERB	O
mesangial	B-Disease	ADJ	B
sclerosis	I-Disease	NOUN	I
,	O	PUNCT	O
XY	O	NOUN	B
pseudohermaphroditism	B-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
Wilms	B-Disease	ADJ	B
tumor	I-Disease	NOUN	I
(	O	PUNCT	O
WT	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
that	O	SCONJ	O
heterozygosity	O	NOUN	B
for	O	ADP	O
a	O	DET	O
targeted	O	VERB	O
murine	O	ADJ	B
Wt1	O	NOUN	B
allele	O	NOUN	B
,	O	PUNCT	O
Wt1	O	NOUN	B
(	O	PUNCT	O
tmT396	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
truncates	O	VERB	B
ZF3	O	NOUN	B
at	O	ADP	O
codon	O	NOUN	B
396	O	NUM	I
,	O	PUNCT	O
induces	O	VERB	O
mesangial	B-Disease	ADJ	B
sclerosis	I-Disease	NOUN	I
characteristic	O	NOUN	O
of	O	ADP	O
DDS	B-Disease	NOUN	B
in	O	ADP	O
adult	O	ADJ	B
heterozygous	O	ADJ	B
and	O	CCONJ	O
chimeric	O	ADJ	B
mice	O	NOUN	I
.	O	PUNCT	O


Mechanism	O	NOUN	B
of	O	ADP	O
increased	O	VERB	B
iron	O	NOUN	B
absorption	O	NOUN	I
in	O	ADP	O
murine	O	ADJ	B
model	O	NOUN	B
of	O	ADP	O
hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
:	O	PUNCT	O
increased	O	VERB	B
duodenal	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
iron	O	NOUN	B
transporter	O	NOUN	I
DMT1	O	NOUN	B
.	O	PUNCT	O


Hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
HH	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
common	O	ADJ	O
autosomal	B-Disease	ADJ	B
recessive	I-Disease	ADJ	O
disorder	I-Disease	NOUN	O
characterized	O	VERB	B
by	O	ADP	O
tissue	O	NOUN	B
iron	O	NOUN	B
deposition	O	NOUN	I
secondary	O	ADJ	B
to	O	PART	I
excessive	O	ADJ	B
dietary	O	ADJ	B
iron	O	NOUN	O
absorption	O	NOUN	O
.	O	PUNCT	O


Neurophysiologic	O	ADJ	B
follow	O	NOUN	B
-	O	PUNCT	O
up	O	NOUN	O
of	O	ADP	O
long	O	ADJ	B
-	O	PUNCT	O
term	O	NOUN	B
dietary	O	ADJ	B
treatment	O	NOUN	I
in	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
adrenoleukodystrophy	B-Disease	NOUN	B
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
To	O	PART	O
monitor	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
dietary	O	ADJ	B
treatment	O	NOUN	I
in	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
adrenoleukodystrophy	B-Disease	NOUN	I
(	O	PUNCT	O
ALD	B-Disease	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
somatosensory	O	ADJ	B
evoked	O	VERB	I
potentials	O	NOUN	I
(	O	PUNCT	O
SEPs	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
motor	O	NOUN	B
evoked	O	VERB	I
potentials	O	NOUN	I
(	O	PUNCT	O
MEPs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Three	O	NUM	O
of	O	ADP	O
these	O	DET	O
patients	O	NOUN	B
had	O	AUX	O
pure	O	ADJ	O
spinal	B-Disease	ADJ	B
SEP	I-Disease	NOUN	O
abnormalities	I-Disease	NOUN	O
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
remaining	O	VERB	O
two	O	NUM	O
patients	O	NOUN	B
SEPs	O	NOUN	B
showed	O	VERB	O
signs	O	NOUN	O
of	O	ADP	O
involvement	O	NOUN	B
of	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
spinal	O	ADJ	B
and	O	CCONJ	O
cerebral	O	ADJ	B
somatosensory	O	ADJ	I
tracts	O	NOUN	I
.	O	PUNCT	O


After	O	ADP	O
treatment	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
three	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
pure	O	ADJ	O
spinal	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
showed	O	VERB	O
clinical	O	ADJ	B
and	O	CCONJ	O
neurophysiologic	O	ADJ	B
worsening	O	NOUN	O
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
two	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
a	O	DET	O
more	O	ADV	O
advanced	O	ADJ	B
stage	O	NOUN	I
of	O	ADP	O
disease	O	NOUN	O
(	O	PUNCT	O
exhibited	O	VERB	O
by	O	ADP	O
SEPs	O	NOUN	B
)	O	PUNCT	O
showed	O	VERB	O
substantially	O	ADV	O
unchanged	O	ADJ	B
clinical	O	ADJ	B
and	O	CCONJ	O
neurophysiologic	O	ADJ	B
features	O	NOUN	B
.	O	PUNCT	O


GCH1	O	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
a	O	DET	O
patient	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
oromandibular	B-Disease	ADJ	B
dystonia	I-Disease	NOUN	I
.	O	PUNCT	O


Germline	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
Korean	O	ADJ	B
familial	B-Disease	ADJ	B
adenomatous	I-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
patients	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
extensively	O	ADV	O
analyzed	O	VERB	O
genomic	O	ADJ	B
DNA	O	NOUN	I
and	O	CCONJ	O
messenger	O	NOUN	B
RNA	O	NOUN	I
(	O	PUNCT	O
mRNA	O	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
62	O	NUM	O
unrelated	O	ADJ	O
Korean	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
familial	B-Disease	ADJ	B
adenomatous	I-Disease	ADJ	I
polyposis	I-Disease	NOUN	I
(	O	PUNCT	O
FAP	B-Disease	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
identification	O	NOUN	B
of	O	ADP	O
germline	O	NOUN	B
adenomatous	B-Disease	ADJ	I
polyposis	I-Disease	NOUN	I
coli	I-Disease	X	I
(	O	PUNCT	O
APC	B-Disease	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	B
mutations	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
confirm	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
mutation	O	NOUN	B
detection	O	NOUN	O
rate	O	NOUN	B
with	O	ADP	O
PTT	O	PROPN	B
was	O	AUX	O
superior	O	ADJ	O
to	O	PART	O
that	O	DET	O
with	O	ADP	O
SSCP	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
suggest	O	VERB	O
that	O	SCONJ	O
PTT	O	PROPN	B
would	O	AUX	O
be	O	AUX	O
a	O	DET	O
more	O	ADV	O
practical	O	ADJ	O
screening	O	NOUN	B
method	O	NOUN	I
to	O	PART	O
detect	O	VERB	B
germline	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
FAP	B-Disease	NOUN	B
patients	O	NOUN	B
.	O	PUNCT	O


Molecular	O	ADJ	B
epidemiology	O	NOUN	I
of	O	ADP	O
C9	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
heterozygotes	O	NOUN	B
with	O	ADP	O
an	O	DET	O
Arg95Stop	O	ADJ	B
mutation	O	NOUN	I
of	O	ADP	O
the	O	DET	O
C9	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
Japan	O	PROPN	B
.	O	PUNCT	O


An	O	DET	O
estimated	O	ADJ	B
frequency	O	NOUN	B
(	O	PUNCT	O
0	O	NUM	O
.	O	PUNCT	O
12	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
of	O	ADP	O
complete	O	ADJ	B
C9	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
due	O	ADJ	O
to	O	PART	O
homozygous	O	ADJ	B
Arg95Stop	O	ADJ	B
mutation	O	NOUN	I
was	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
frequencies	O	NOUN	B
determined	O	VERB	O
by	O	ADP	O
serological	O	ADJ	B
studies	O	NOUN	I


The	O	DET	O
hereditary	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
protein	O	NOUN	I
,	O	PUNCT	O
HFE	O	NOUN	B
,	O	PUNCT	O
specifically	O	ADV	O
regulates	O	VERB	B
transferrin	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
iron	O	NOUN	B
uptake	O	NOUN	I
in	O	ADP	O
HeLa	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Mutation	O	NOUN	B
and	O	CCONJ	O
haplotype	O	NOUN	B
studies	O	NOUN	B
of	O	ADP	O
familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	B
fever	I-Disease	NOUN	I
reveal	O	VERB	O
new	O	ADJ	O
ancestral	O	ADJ	B
relationships	O	NOUN	B
and	O	CCONJ	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
high	O	ADJ	B
carrier	O	NOUN	I
frequency	O	NOUN	O
with	O	ADP	O
reduced	O	VERB	B
penetrance	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Ashkenazi	O	PROPN	B
Jewish	O	ADJ	B
population	O	NOUN	I
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	I
fever	I-Disease	NOUN	I
(	O	PUNCT	O
FMF	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
recessive	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
episodes	O	NOUN	B
of	O	ADP	O
fever	O	NOUN	B
with	O	ADP	O
serositis	B-Disease	NOUN	B
or	O	CCONJ	O
synovitis	B-Disease	NOUN	B
.	O	PUNCT	O


Nevertheless	O	ADV	O
,	O	PUNCT	O
E148Q	O	NOUN	B
helps	O	VERB	O
account	O	NOUN	O
for	O	ADP	O
recessive	O	ADJ	B
inheritance	O	NOUN	I
in	O	ADP	O
an	O	DET	O
Ashkenazi	O	ADJ	B
family	O	NOUN	B
previously	O	ADV	O
reported	O	VERB	O
as	O	ADP	O
an	O	DET	O
unusual	O	ADJ	B
case	O	NOUN	B
of	O	ADP	O
dominantly	O	ADV	O
inherited	O	VERB	B
FMF	B-Disease	NOUN	B
.	O	PUNCT	O


Autoimmune	B-Disease	ADJ	B
lymphoproliferative	I-Disease	ADJ	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
ALPS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
disorder	B-Disease	NOUN	B
of	I-Disease	ADP	O
lymphocyte	I-Disease	NOUN	B
homeostasis	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
immunological	I-Disease	ADJ	B
tolerance	I-Disease	NOUN	I
.	O	PUNCT	O


Two	O	NUM	O
missense	O	NOUN	B
Fas	O	NOUN	B
variants	O	NOUN	B
,	O	PUNCT	O
not	O	PART	O
restricted	O	ADJ	O
to	O	PART	O
patients	O	NOUN	B
with	O	ADP	O
ALPS	B-Disease	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Mutations	O	NOUN	B
causing	O	VERB	O
disruption	O	NOUN	B
of	O	ADP	O
the	O	DET	O
intracellular	O	ADJ	B
Fas	O	NOUN	B
death	O	NOUN	I
domain	O	NOUN	O
also	O	ADV	O
showed	O	VERB	O
a	O	DET	O
higher	O	ADJ	O
penetrance	O	NOUN	B
of	O	ADP	O
ALPS	B-Disease	NOUN	B
phenotype	O	NOUN	B
features	O	NOUN	B
in	O	ADP	O
mutation	O	NOUN	B
-	O	PUNCT	O
bearing	O	VERB	B
relatives	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
location	O	NOUN	B
of	O	ADP	O
mutations	O	NOUN	B
within	O	ADP	O
APT1	O	NOUN	B
strongly	O	ADV	O
influences	O	VERB	B
the	O	DET	O
development	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
severity	O	NOUN	B
of	O	ADP	O
ALPS	B-Disease	NOUN	B
.	O	PUNCT	O


Genetic	B-Disease	ADJ	B
hemochromatosis	I-Disease	NOUN	I
(	O	PUNCT	O
GH	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
believed	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
disease	O	NOUN	B
restricted	O	ADJ	B
to	O	PART	O
those	O	DET	O
of	O	ADP	O
European	O	ADJ	B
ancestry	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
northwestern	O	ADJ	B
Europe	O	PROPN	I
,	O	PUNCT	O
>	O	PROPN	O
80	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
GH	B-Disease	NOUN	B
patients	O	NOUN	B
are	O	AUX	O
homozygous	O	ADJ	B
for	O	ADP	O
one	O	NUM	O
mutation	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
substitution	O	NOUN	B
of	O	ADP	O
tyrosine	O	NOUN	B
for	O	ADP	O
cysteine	O	NOUN	B
at	O	ADP	O
position	O	NOUN	O
282	O	NUM	O
(	O	PUNCT	O
C282Y	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
unprocessed	O	ADJ	B
protein	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
retrospectively	O	ADV	B
analyzed	O	VERB	I
837	O	NUM	O
random	O	ADJ	B
anonymized	O	VERB	B
dried	O	VERB	O
blood	O	NOUN	O
spot	O	NOUN	O
(	O	PUNCT	O
DBS	O	NOUN	B
)	O	PUNCT	O
samples	O	NOUN	B
from	O	ADP	O
neonatal	O	ADJ	B
screening	O	NOUN	B
programs	O	NOUN	I
in	O	ADP	O
Scandinavia	O	PROPN	B
for	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
HFE	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
candidate	O	NOUN	O
gene	O	NOUN	B
for	O	ADP	O
hemochromatosis	B-Disease	NOUN	B
.	O	PUNCT	O


Alkaptonuria	B-Disease	NOUN	B
(	O	PUNCT	O
aku	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
an	O	DET	O
inborn	B-Disease	ADJ	B
error	I-Disease	NOUN	I
of	I-Disease	ADP	O
metabolism	I-Disease	NOUN	B
caused	O	VERB	O
by	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
homogentisate	O	NOUN	B
1	O	NUM	I
,	O	PUNCT	O
2	O	NUM	B
-	O	PUNCT	O
dioxygenase	O	NOUN	B
(	O	PUNCT	O
HGD	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
in	O	ADP	O
a	O	DET	O
mouse	O	NOUN	B
model	O	NOUN	I
created	O	VERB	O
by	O	ADP	O
ethylnitrosourea	O	NOUN	B
mutagenesis	O	NOUN	I
but	O	CCONJ	O
the	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
these	O	DET	O
mice	O	NOUN	B
has	O	AUX	O
not	O	PART	O
previously	O	ADV	O
been	O	AUX	O
identified	O	VERB	B
.	O	PUNCT	O


Non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	O
associated	O	VERB	B
with	O	ADP	I
enlarged	B-Disease	ADJ	B
vestibular	I-Disease	ADJ	B
aqueduct	I-Disease	NOUN	I
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
PDS	B-Disease	NOUN	B
mutations	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
,	O	PUNCT	O
seven	O	NUM	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
PDS	B-Disease	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
PDS	O	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
gene	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
found	O	VERB	O
in	O	ADP	O
families	O	NOUN	B
of	O	ADP	O
non	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
syndromic	I-Disease	ADJ	B
sensorineural	I-Disease	ADJ	O
hearing	I-Disease	NOUN	O
loss	I-Disease	NOUN	O
with	O	ADP	O
EVA	B-Disease	NOUN	B
.	O	PUNCT	O


Mutational	O	ADJ	B
analysis	O	NOUN	I
and	O	CCONJ	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
correlation	O	NOUN	B
of	O	ADP	O
29	O	NUM	O
unrelated	O	ADJ	O
Japanese	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
adrenoleukodystrophy	I-Disease	NOUN	B
.	O	PUNCT	O


The	O	DET	O
classic	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
ALD	B-Disease	NOUN	B
usually	O	ADV	O
has	O	AUX	O
onset	O	NOUN	O
in	O	ADP	O
childhood	O	NOUN	O
(	O	PUNCT	O
childhood	B-Disease	NOUN	B
cerebral	I-Disease	ADJ	I
ALD	I-Disease	NOUN	I
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
rapid	O	ADJ	O
neurologic	B-Disease	ADJ	B
deterioration	I-Disease	NOUN	B
leading	O	VERB	O
to	O	PART	O
a	O	DET	O
vegetative	O	ADJ	B
state	O	NOUN	I
.	O	PUNCT	O


Milder	O	ADJ	B
phenotypes	O	NOUN	B
such	O	ADJ	O
as	O	ADP	O
adrenomyeloneuropathy	B-Disease	ADJ	B
and	O	CCONJ	O
Addison	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
only	O	ADV	O
also	O	ADV	O
have	O	AUX	O
been	O	AUX	O
recognized	O	VERB	O
.	O	PUNCT	O


METHODS	O	NOUN	O
The	O	DET	O
29	O	NUM	O
patients	O	NOUN	B
comprised	O	VERB	O
13	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
childhood	B-Disease	NOUN	B
cerebral	I-Disease	ADJ	I
ALD	I-Disease	NOUN	I
,	O	PUNCT	O
11	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
cerebral	B-Disease	ADJ	B
ALD	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
5	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adrenomyeloneuropathy	B-Disease	NOUN	B
.	O	PUNCT	O


RESULTS	O	VERB	O
Three	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
adult	O	ADJ	B
-	O	PUNCT	O
onset	O	NOUN	B
cerebral	B-Disease	ADJ	B
ALD	I-Disease	NOUN	I
were	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
having	O	VERB	O
large	O	ADJ	O
genomic	O	ADJ	B
rearrangements	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
remaining	O	VERB	O
26	O	NUM	O
patients	O	NOUN	B
were	O	AUX	O
identified	O	VERB	B
as	O	ADP	O
having	O	VERB	O
21	O	NUM	O
independent	O	ADJ	O
mutations	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
12	O	NUM	O
novel	O	ADJ	B
mutations	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
small	O	ADJ	B
nucleotide	O	NOUN	B
alterations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ALD	B-Disease	NOUN	B
gene	O	NOUN	B
.	O	PUNCT	O


One	O	NUM	O
of	O	ADP	O
the	O	DET	O
target	O	NOUN	B
genes	O	NOUN	O
for	O	ADP	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	PROPN	B
/	O	SYM	O
TCF	O	PROPN	B
encodes	O	VERB	O
c	O	X	O
-	O	PUNCT	O
MYC	O	NOUN	B
,	O	PUNCT	O
explaining	O	VERB	O
why	O	SCONJ	O
constitutive	O	ADJ	B
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
WNT	O	NOUN	B
pathway	O	NOUN	I
can	O	AUX	O
lead	O	VERB	O
to	O	ADP	O
cancer	B-Disease	NOUN	B
,	O	PUNCT	O
particularly	O	ADV	O
in	O	ADP	O
the	O	DET	O
colon	O	NOUN	B
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
discovered	O	VERB	O
that	O	SCONJ	O
transgenic	O	ADJ	B
mice	O	NOUN	I
expressing	O	VERB	B
an	O	DET	O
activated	O	VERB	B
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
are	O	AUX	O
predisposed	O	VERB	O
to	O	ADP	O
developing	O	VERB	O
skin	B-Disease	NOUN	B
tumours	I-Disease	NOUN	I
resembling	O	VERB	O
pilomatricomas	B-Disease	NOUN	B
.	O	PUNCT	O


Given	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
skin	O	NOUN	B
of	O	ADP	O
these	O	DET	O
adult	O	ADJ	B
mice	O	NOUN	B
also	O	ADV	O
exhibits	O	VERB	O
signs	O	NOUN	O
of	O	ADP	O
de	O	X	O
novo	O	X	O
hair	O	NOUN	B
-	O	PUNCT	O
follicle	O	NOUN	B
morphogenesis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
wondered	O	VERB	O
whether	O	SCONJ	O
human	O	ADJ	B
pilomatricomas	B-Disease	NOUN	B
might	O	AUX	O
originate	O	VERB	O
from	O	ADP	O
hair	O	NOUN	B
matrix	O	NOUN	I
cells	O	NOUN	I
and	O	CCONJ	O
whether	O	SCONJ	O
they	O	PRON	O
might	O	AUX	O
possess	O	VERB	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
-	O	PUNCT	O
stabilizing	O	VERB	B
mutations	O	NOUN	B
.	O	PUNCT	O


At	O	ADV	O
least	O	ADV	O
75	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
these	O	DET	O
tumours	B-Disease	NOUN	B
possess	O	VERB	O
mutations	O	NOUN	B
affecting	O	VERB	B
the	O	DET	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
segment	O	NOUN	B
,	O	PUNCT	O
normally	O	ADV	O
involved	O	VERB	O
in	O	ADP	O
phosphorylation	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
,	O	PUNCT	O
ubiquitin	O	NOUN	B
-	O	PUNCT	O
mediated	O	VERB	B
degradation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
CTNNB1	O	NOUN	B
mutations	O	NOUN	B
is	O	AUX	O
greater	O	ADJ	O
than	O	ADP	O
in	O	ADP	O
all	O	DET	O
other	O	ADJ	O
human	O	ADJ	B
tumours	B-Disease	NOUN	I
examined	O	VERB	B
thus	O	ADV	O
far	O	ADV	O
,	O	PUNCT	O
and	O	CCONJ	O
directly	O	ADV	O
implicates	O	VERB	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
/	O	SYM	O
LEF	O	NOUN	B
misregulation	O	NOUN	B
as	O	ADP	O
the	O	DET	O
major	O	ADJ	O
cause	O	NOUN	O
of	O	ADP	O
hair	O	NOUN	B
matrix	O	NOUN	I
cell	O	NOUN	I
tumorigenesis	O	NOUN	B
in	O	ADP	O
humans	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
syndromic	B-Disease	ADJ	B
deafness	I-Disease	NOUN	I
and	O	CCONJ	O
characterized	O	VERB	B
by	O	ADP	O
congenital	O	ADJ	B
sensorineural	B-Disease	ADJ	I
hearing	I-Disease	NOUN	I
loss	I-Disease	NOUN	I
and	O	CCONJ	O
goitre	B-Disease	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
pendrin	O	NOUN	B
functions	O	VERB	B
as	O	ADP	O
a	O	DET	O
transporter	O	NOUN	B
of	O	ADP	O
chloride	O	NOUN	B
and	O	CCONJ	O
iodide	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
sulfate	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
may	O	AUX	O
provide	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
thyroid	O	NOUN	B
physiology	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
pathophysiology	O	NOUN	B
of	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


HFE	O	NOUN	B
mutations	O	NOUN	B
analysis	O	NOUN	O
in	O	ADP	O
711	O	NUM	O
hemochromatosis	B-Disease	NOUN	B
probands	O	NOUN	B
:	O	PUNCT	O
evidence	O	NOUN	B
for	O	ADP	O
S65C	O	NOUN	B
implication	O	NOUN	B
in	O	ADP	O
mild	O	ADJ	B
form	O	NOUN	I
of	O	ADP	O
hemochromatosis	B-Disease	NOUN	B
.	O	PUNCT	O


Two	O	NUM	O
missense	O	NOUN	B
mutations	O	NOUN	I
have	O	AUX	O
been	O	AUX	O
described	O	VERB	O
C282Y	O	NOUN	B
,	O	PUNCT	O
accounting	O	VERB	O
for	O	ADP	O
80	O	NUM	O
%	O	NOUN	O
to	O	PART	O
90	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
H63D	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
milder	O	ADJ	O
form	O	NOUN	O
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
representing	O	VERB	O
40	O	NUM	O
%	O	NOUN	O
to	O	PART	O
70	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
non	O	ADJ	B
-	O	PUNCT	O
C282Y	O	NOUN	B
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
confirm	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
C282Y	O	NOUN	B
substitution	O	NOUN	B
was	O	AUX	O
the	O	DET	O
main	O	ADJ	O
mutation	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
hemochromatosis	B-Disease	NOUN	B
,	O	PUNCT	O
accounting	O	VERB	O
for	O	ADP	O
85	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
carrier	O	NOUN	B
chromosomes	O	NOUN	I
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
H63D	O	NOUN	B
substitution	O	NOUN	B
represented	O	VERB	O
39	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
that	O	PRON	O
did	O	AUX	O
not	O	PART	O
carry	O	VERB	O
the	O	DET	O
C282Y	O	NOUN	B
mutation	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
enrichment	O	NOUN	O
of	O	ADP	O
S65C	O	NOUN	B
among	O	ADP	O
HH	B-Disease	NOUN	B
chromosomes	O	NOUN	B
suggests	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
S65C	O	NOUN	B
substitution	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
mild	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
hemochromatosis	B-Disease	NOUN	B
.	O	PUNCT	O


The	O	DET	O
objective	O	NOUN	B
of	O	ADP	O
this	O	DET	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
provide	O	VERB	O
more	O	ADV	O
accurate	O	ADJ	B
frequency	O	NOUN	B
estimates	O	NOUN	B
of	O	ADP	O
breast	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
susceptibility	O	NOUN	O
gene	O	NOUN	O
1	O	NUM	O
(	O	PUNCT	O
BRCA1	O	NOUN	B
)	O	PUNCT	O
germline	O	NOUN	B
alterations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
population	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
population	O	NOUN	B
-	O	PUNCT	O
based	O	VERB	B
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
study	O	NOUN	B
reporting	O	VERB	O
BRCA1	O	NOUN	B
alterations	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
a	O	DET	O
comprehensive	O	ADJ	B
screen	O	NOUN	B
of	O	ADP	O
the	O	DET	O
entire	O	ADJ	O
coding	O	VERB	B
region	O	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
patients	O	NOUN	B
had	O	AUX	O
a	O	DET	O
family	O	NOUN	B
history	O	NOUN	I
of	O	ADP	I
breast	B-Disease	NOUN	B
or	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
frequency	O	NOUN	B
distribution	O	NOUN	B
of	O	ADP	O
common	O	ADJ	O
polymorphisms	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
in	O	ADP	O
the	O	DET	O
91	O	NUM	O
Caucasian	O	ADJ	B
cancer	B-Disease	NOUN	B
cases	O	NOUN	B
in	O	ADP	O
this	O	DET	O
series	O	NOUN	B
and	O	CCONJ	O
24	O	NUM	O
sister	O	NOUN	B
controls	O	NOUN	I
using	O	VERB	O
allele	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
amplification	O	NOUN	B
.	O	PUNCT	O


Adrenoleukodystrophy	O	NOUN	B
-	O	PUNCT	O
related	O	VERB	B
protein	O	NOUN	B
can	O	AUX	O
compensate	O	VERB	O
functionally	O	ADV	O
for	O	ADP	O
adrenoleukodystrophy	B-Disease	NOUN	B
protein	I-Disease	NOUN	I
deficiency	I-Disease	NOUN	I
(	O	PUNCT	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
ALD	I-Disease	PROPN	B
)	O	PUNCT	O
:	O	PUNCT	O
implications	O	NOUN	O
for	O	ADP	O
therapy	O	NOUN	B
.	O	PUNCT	O


Inherited	B-Disease	ADJ	B
defects	I-Disease	NOUN	B
in	O	ADP	O
the	O	DET	O
peroxisomal	O	ADJ	B
ATP	O	NOUN	I
-	O	PUNCT	O
binding	O	VERB	B
cassette	O	NOUN	I
(	O	PUNCT	O
ABC	O	NOUN	B
)	O	PUNCT	O
transporter	O	NOUN	O
adrenoleukodystrophy	B-Disease	NOUN	O
protein	O	NOUN	O
(	O	PUNCT	O
ALDP	O	NOUN	B
)	O	PUNCT	O
lead	O	VERB	O
to	O	PART	O
the	O	DET	O
lethal	O	ADJ	B
peroxisomal	B-Disease	ADJ	B
disorder	I-Disease	NOUN	I
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
adrenoleukodystrophy	I-Disease	NOUN	B
(	O	PUNCT	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
ALD	I-Disease	PROPN	B
)	O	PUNCT	O
,	O	PUNCT	O
for	O	ADP	O
which	O	DET	O
no	O	DET	O
efficient	O	ADJ	B
treatment	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
established	O	VERB	O
so	O	ADV	O
far	O	ADV	O
.	O	PUNCT	O


Germline	O	NOUN	B
mutations	O	NOUN	I
of	O	ADP	O
the	O	DET	O
Brca1	O	NOUN	B
tumor	B-Disease	NOUN	B
suppressor	O	NOUN	I
gene	O	NOUN	I
predispose	O	VERB	O
women	O	NOUN	B
to	O	ADP	O
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancers	I-Disease	NOUN	I
.	O	PUNCT	O


Mutant	O	ADJ	B
fibroblasts	O	NOUN	B
contain	O	VERB	O
multiple	O	ADJ	B
,	O	PUNCT	O
functional	O	ADJ	B
centrosomes	O	NOUN	O
,	O	PUNCT	O
which	O	DET	O
lead	O	VERB	O
to	O	PART	O
unequal	O	ADJ	O
chromosome	O	NOUN	B
segregation	O	NOUN	I
,	O	PUNCT	O
abnormal	O	ADJ	B
nuclear	O	ADJ	O
division	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
aneuploidy	B-Disease	NOUN	B
.	O	PUNCT	O


Heterozygous	O	ADJ	B
mutations	O	NOUN	I
in	O	ADP	O
the	O	DET	O
CD95	O	NOUN	B
(	O	PUNCT	O
APO	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
/	O	SYM	O
Fas	O	NOUN	B
)	O	PUNCT	O
receptor	O	NOUN	O
occur	O	VERB	O
in	O	ADP	O
most	O	ADJ	O
individuals	O	NOUN	B
with	O	ADP	O
autoimmune	B-Disease	ADJ	B
lymphoproliferative	I-Disease	ADJ	I
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
ALPS	B-Disease	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
dominantly	O	ADV	O
interfere	O	VERB	B
with	O	ADP	I
apoptosis	O	NOUN	B
by	O	ADP	O
an	O	DET	O
unknown	O	ADJ	O
mechanism	O	NOUN	B
.	O	PUNCT	O


Despite	O	SCONJ	O
heterozygosity	O	NOUN	B
for	O	ADP	O
the	O	DET	O
abnormal	O	ADJ	B
allele	O	NOUN	B
,	O	PUNCT	O
lymphocytes	O	NOUN	B
from	O	ADP	O
ALPS	B-Disease	NOUN	B
patients	O	NOUN	B
showed	O	VERB	O
markedly	O	ADV	O
decreased	O	VERB	B
FADD	O	NOUN	B
association	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
caspase	O	NOUN	B
recruitment	O	NOUN	B
and	O	CCONJ	O
activation	O	NOUN	B
after	O	ADP	O
CD95	O	NOUN	B
crosslinking	O	NOUN	B
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
alkaptonuria	B-Disease	NOUN	B
(	O	PUNCT	O
AKU	B-Disease	NOUN	B
)	O	PUNCT	O
mutations	O	NOUN	B
and	O	CCONJ	O
polymorphisms	O	NOUN	B
reveals	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
CCC	O	NOUN	B
sequence	O	NOUN	I
motif	O	NOUN	B
is	O	AUX	O
a	O	DET	O
mutational	O	ADJ	B
hot	O	ADJ	O
spot	O	NOUN	O
in	O	ADP	O
the	O	DET	O
homogentisate	O	NOUN	B
1	O	NUM	I
,	O	PUNCT	O
2	O	NUM	O
dioxygenase	O	NOUN	O
gene	O	NOUN	O
(	O	PUNCT	O
HGO	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Herein	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
haplotype	O	NOUN	B
and	O	CCONJ	O
mutational	O	ADJ	B
analyses	O	NOUN	I
of	O	ADP	O
HGO	O	NOUN	B
in	O	ADP	O
seven	O	NUM	O
new	O	ADJ	O
AKU	B-Disease	NOUN	B
pedigrees	O	NOUN	B
.	O	PUNCT	O


Fabry	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
:	O	PUNCT	O
identification	O	NOUN	B
of	O	ADP	O
novel	O	ADJ	B
alpha	O	NOUN	B
-	O	PUNCT	O
galactosidase	O	NOUN	B
A	O	NOUN	O
mutations	O	NOUN	B
and	O	CCONJ	O
molecular	O	ADJ	B
carrier	O	NOUN	I
detection	O	NOUN	I
by	O	ADP	O
use	O	NOUN	O
of	O	ADP	O
fluorescent	O	ADJ	B
chemical	O	ADJ	I
cleavage	O	NOUN	I
of	O	ADP	O
mismatches	O	NOUN	B
.	O	PUNCT	O


Fabry	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
FD	B-Disease	PROPN	B
)	O	PUNCT	O
(	O	PUNCT	O
angiokeratoma	B-Disease	NOUN	B
corporis	I-Disease	NOUN	I
diffusum	I-Disease	NOUN	I
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
inborn	I-Disease	ADJ	B
error	I-Disease	NOUN	I
of	I-Disease	ADP	O
glycosphingolipid	I-Disease	NOUN	B
metabolism	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
defects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
lysosomal	O	ADJ	B
alpha	O	NOUN	I
-	O	PUNCT	O
galactosidase	O	NOUN	B
A	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
GLA	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


While	O	SCONJ	O
demonstration	O	NOUN	O
of	O	ADP	O
alpha	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
galactosidase	I-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
in	O	ADP	O
leukocytes	O	NOUN	B
is	O	AUX	O
diagnostic	O	ADJ	B
in	O	ADP	O
affected	O	VERB	B
males	O	NOUN	B
,	O	PUNCT	O
enzymatic	O	ADJ	B
detection	O	NOUN	I
of	O	ADP	O
female	O	ADJ	B
carriers	O	NOUN	B
is	O	AUX	O
often	O	ADV	O
inconclusive	O	ADJ	B
,	O	PUNCT	O
due	O	ADP	O
to	O	ADP	O
random	O	ADJ	B
X	O	NOUN	B
-	O	PUNCT	O
chromosomal	O	ADJ	B
inactivation	O	NOUN	B
,	O	PUNCT	O
underlining	O	VERB	O
the	O	DET	O
need	O	NOUN	O
of	O	ADP	O
molecular	O	ADJ	B
investigations	O	NOUN	I
for	O	ADP	O
accurate	O	ADJ	B
genetic	O	ADJ	B
counseling	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
Pelizaeus	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Merzbacher	I-Disease	PROPN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
MIM	O	NOUN	B
312080	O	NUM	I
)	O	PUNCT	O
was	O	AUX	O
made	O	VERB	O
in	O	ADP	O
a	O	DET	O
young	O	ADJ	B
boy	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
proband	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
carry	O	VERB	O
the	O	DET	O
duplication	O	NOUN	B
,	O	PUNCT	O
thus	O	ADV	O
confirming	O	VERB	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
Pelizaeus	B-Disease	PROPN	B
Merzbacher	I-Disease	PROPN	I
disease	I-Disease	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
neither	O	CCONJ	O
the	O	DET	O
aunt	O	NOUN	B
nor	O	CCONJ	O
the	O	DET	O
fetus	O	NOUN	B
carried	O	VERB	O
a	O	DET	O
duplication	O	NOUN	B
.	O	PUNCT	O
.	O	PUNCT	O


Inactivation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adenomatous	B-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
coli	I-Disease	X	I
(	O	PUNCT	O
APC	B-Disease	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	B
product	O	NOUN	I
initiates	O	VERB	B
colorectal	O	ADJ	B
tumorigenesis	O	NOUN	O
.	O	PUNCT	O


Together	O	ADV	O
with	O	ADP	O
the	O	DET	O
fact	O	NOUN	O
that	O	SCONJ	O
both	O	CCONJ	O
germ	O	NOUN	B
-	O	PUNCT	O
line	O	NOUN	B
and	O	CCONJ	O
sporadic	O	ADJ	B
APC	B-Disease	NOUN	B
mutations	O	NOUN	O
cluster	O	VERB	O
in	O	ADP	O
the	O	DET	O
central	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
this	O	DET	O
points	O	VERB	O
to	O	PART	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
certain	O	ADJ	O
APC	B-Disease	NOUN	B
mutants	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
provide	O	VERB	O
experimental	O	ADJ	B
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
dominant	O	ADJ	B
negative	O	ADJ	B
effect	O	NOUN	B
of	O	ADP	O
APC	B-Disease	NOUN	B
gene	O	NOUN	I
products	O	NOUN	O
associated	O	VERB	B
with	O	ADP	I
severe	O	ADJ	B
polyposis	B-Disease	NOUN	B
.	O	PUNCT	O


Wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
APC	B-Disease	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	PROPN	B
-	O	PUNCT	O
/	O	SYM	O
Tcf	O	PROPN	B
-	O	PUNCT	O
mediated	O	VERB	B
transcription	O	NOUN	B
was	O	AUX	O
strongly	O	ADV	O
inhibited	O	VERB	B
by	O	ADP	O
a	O	DET	O
mutant	O	ADJ	B
APC	B-Disease	NOUN	B
that	O	PRON	O
is	O	AUX	O
truncated	O	VERB	B
at	O	ADP	O
codon	O	NOUN	B
1309	O	NUM	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
suggest	O	VERB	O
a	O	DET	O
molecular	O	ADJ	B
explanation	O	NOUN	O
for	O	ADP	O
the	O	DET	O
genotype	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
correlation	O	NOUN	B
in	O	ADP	O
FAP	B-Disease	NOUN	B
patients	O	NOUN	B
and	O	CCONJ	O
support	O	VERB	O
the	O	DET	O
idea	O	NOUN	O
that	O	SCONJ	O
colorectal	B-Disease	ADJ	B
tumor	I-Disease	NOUN	I
growth	O	NOUN	I
might	O	AUX	O
be	O	AUX	O
,	O	PUNCT	O
in	O	ADP	O
part	O	NOUN	O
,	O	PUNCT	O
driven	O	VERB	O
by	O	ADP	O
selection	O	NOUN	B
for	O	ADP	O
a	O	DET	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
mutation	O	NOUN	B
cluster	O	NOUN	I
region	O	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Combined	B-Disease	ADJ	B
genetic	I-Disease	ADJ	B
deficiency	I-Disease	NOUN	I
of	I-Disease	ADP	O
C6	I-Disease	NOUN	B
and	I-Disease	CCONJ	O
C7	I-Disease	NOUN	B
in	O	ADP	O
man	O	NOUN	B
.	O	PUNCT	O


No	O	DET	O
clinical	O	ADJ	O
disease	O	NOUN	O
was	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
this	O	DET	O
deficiency	O	NOUN	B
which	O	DET	O
was	O	AUX	O
transmitted	O	VERB	B
through	O	ADP	O
the	O	DET	O
subjects	O	NOUN	B
family	O	NOUN	O
as	O	ADP	O
a	O	DET	O
single	O	ADJ	O
genetic	O	ADJ	B
characteristic	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
C6	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
being	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
silent	O	ADJ	B
allele	O	NOUN	B
at	O	ADP	O
the	O	DET	O
structural	O	ADJ	B
locus	O	NOUN	I
.	O	PUNCT	O


Emery	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	I
dystrophy	I-Disease	NOUN	I
(	O	PUNCT	O
EDMD	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
recessive	I-Disease	ADJ	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
characterized	O	VERB	B
by	O	ADP	O
early	O	ADJ	B
contractures	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
elbows	I-Disease	NOUN	B
,	I-Disease	PUNCT	O
Achilles	I-Disease	NOUN	B
tendons	I-Disease	NOUN	I
and	I-Disease	CCONJ	O
spine	I-Disease	NOUN	B
,	O	PUNCT	O
slowly	O	ADV	O
progressive	O	ADJ	B
muscle	B-Disease	NOUN	B
wasting	I-Disease	NOUN	I
and	O	CCONJ	O
weakness	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
cardiomyopathy	B-Disease	NOUN	B
associated	O	VERB	B
with	O	ADP	I
cardiac	B-Disease	ADJ	B
conduction	I-Disease	NOUN	I
defects	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
comparison	O	NOUN	B
with	O	ADP	O
the	O	DET	O
usual	O	ADJ	O
EDMD	B-Disease	NOUN	B
phenotype	O	NOUN	B
,	O	PUNCT	O
patients	O	NOUN	B
with	O	ADP	O
P183	O	NOUN	B
missense	O	NOUN	I
mutations	O	NOUN	I
have	O	AUX	O
a	O	DET	O
later	O	ADJ	O
age	O	NOUN	B
at	O	ADP	O
onset	O	NOUN	O
of	O	ADP	O
first	O	ADJ	O
symptoms	O	NOUN	B
,	O	PUNCT	O
elbow	B-Disease	NOUN	B
contractures	I-Disease	NOUN	I
,	O	PUNCT	O
ankle	B-Disease	NOUN	B
contractures	I-Disease	NOUN	I
,	O	PUNCT	O
upper	B-Disease	ADJ	B
limb	I-Disease	NOUN	I
weakness	I-Disease	NOUN	I
and	O	CCONJ	O
lower	B-Disease	ADJ	B
limb	I-Disease	NOUN	I
weakness	I-Disease	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
there	O	PRON	O
is	O	AUX	O
no	O	DET	O
difference	O	NOUN	O
for	O	ADP	O
the	O	DET	O
age	O	NOUN	B
at	O	ADP	O
onset	O	NOUN	O
of	O	ADP	O
cardiac	B-Disease	ADJ	B
involvement	I-Disease	NOUN	B
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
report	O	NOUN	B
of	O	ADP	O
protein	O	NOUN	B
studies	O	NOUN	I
on	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
missense	O	NOUN	B
mutations	O	NOUN	I
resulting	O	VERB	O
in	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
features	O	NOUN	I
of	O	ADP	O
EDMD	B-Disease	NOUN	B
.	O	PUNCT	O


Along	O	ADP	O
with	O	ADP	O
cleft	B-Disease	NOUN	B
lip	I-Disease	NOUN	I
/	I-Disease	SYM	O
palate	I-Disease	ADJ	B
and	O	CCONJ	O
lip	B-Disease	NOUN	B
pits	I-Disease	NOUN	I
,	O	PUNCT	O
affected	O	VERB	B
relatives	O	NOUN	B
exhibit	O	VERB	O
developmental	B-Disease	ADJ	B
delays	I-Disease	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
function	O	NOUN	B
of	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
nearby	O	ADV	I
may	O	AUX	O
also	O	ADV	O
be	O	AUX	O
disrupted	O	VERB	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
family	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
phenotype	O	NOUN	B
in	O	ADP	O
three	O	NUM	O
generations	O	NOUN	B
of	O	ADP	O
affected	O	VERB	B
individuals	O	NOUN	B
was	O	AUX	O
confined	O	VERB	O
to	O	PART	O
the	O	DET	O
cardinal	O	ADJ	O
signs	O	NOUN	B
of	O	ADP	O
VWS	B-Disease	NOUN	B
.	O	PUNCT	O


Splicing	O	NOUN	B
defects	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
gene	O	NOUN	I
,	O	PUNCT	O
ATM	O	NOUN	B
:	O	PUNCT	O
underlying	O	VERB	O
mutations	O	NOUN	B
and	O	CCONJ	O
consequences	O	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
resulting	O	VERB	O
in	O	ADP	O
defective	O	ADJ	B
splicing	O	NOUN	B
constitute	O	VERB	O
a	O	DET	O
significant	O	ADJ	O
proportion	O	NOUN	B
(	O	PUNCT	O
30	O	NUM	O
/	O	SYM	O
62	O	NUM	O
[	O	PUNCT	O
48	O	NUM	O
%	O	NOUN	O
]	O	PUNCT	O
)	O	PUNCT	O
of	O	ADP	O
a	O	DET	O
new	O	ADJ	O
series	O	NOUN	O
of	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
ATM	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
ataxia	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
telangiectasia	I-Disease	NOUN	B
(	O	PUNCT	O
AT	B-Disease	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
were	O	AUX	O
detected	O	VERB	B
by	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
-	O	PUNCT	O
truncation	O	NOUN	B
assay	O	NOUN	B
followed	O	VERB	O
by	O	ADP	O
sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
genomic	O	ADJ	B
DNA	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
identified	O	VERB	B
the	O	DET	O
alpha	O	NOUN	B
-	O	PUNCT	O
cardiac	O	ADJ	B
actin	O	NOUN	I
gene	O	NOUN	I
(	O	PUNCT	O
ACTC	O	NOUN	B
)	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
disease	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
a	O	DET	O
pedigree	O	NOUN	B
suffering	O	NOUN	I
from	O	ADP	O
familial	B-Disease	ADJ	B
hypertrophic	I-Disease	ADJ	I
cardiomyopathy	I-Disease	NOUN	I
(	O	PUNCT	O
FHC	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Linkage	O	NOUN	B
analyses	O	NOUN	I
excluded	O	VERB	O
all	O	DET	O
the	O	DET	O
previously	O	ADV	O
reported	O	VERB	O
FHC	B-Disease	NOUN	B
loci	O	NOUN	B
as	O	ADP	O
possible	O	ADJ	O
disease	O	NOUN	B
loci	O	NOUN	I
in	O	ADP	O
the	O	DET	O
family	O	NOUN	B
studied	O	VERB	O
,	O	PUNCT	O
with	O	ADP	O
lod	O	NOUN	B
scores	O	NOUN	I
varying	O	VERB	O
between	O	ADP	O
-	O	SYM	O
2	O	NUM	O
.	O	PUNCT	O


Overgrowth	B-Disease	NOUN	B
of	I-Disease	ADP	O
oral	I-Disease	ADJ	B
mucosa	I-Disease	NOUN	I
and	I-Disease	CCONJ	O
facial	I-Disease	ADJ	B
skin	I-Disease	NOUN	I
,	O	PUNCT	O
a	O	DET	O
novel	O	ADJ	O
feature	O	NOUN	O
of	O	ADP	O
aspartylglucosaminuria	B-Disease	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
examine	O	VERB	O
66	O	NUM	O
Finnish	O	ADJ	B
AGU	B-Disease	NOUN	B
patients	O	NOUN	B
for	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
the	O	DET	O
oral	O	ADJ	B
mucosa	O	NOUN	I
and	O	CCONJ	O
44	O	NUM	O
of	O	ADP	O
these	O	DET	O
for	O	ADP	O
changes	O	NOUN	B
in	O	ADP	O
facial	O	ADJ	B
skin	O	NOUN	I
.	O	PUNCT	O


Skin	O	NOUN	B
was	O	AUX	O
seborrhoeic	O	ADJ	B
in	O	ADP	O
adolescent	O	ADJ	B
and	O	CCONJ	O
adult	O	ADJ	B
patients	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
erythema	B-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
facial	I-Disease	ADJ	B
skin	I-Disease	NOUN	I
already	O	ADV	O
common	O	ADJ	O
in	O	ADP	O
childhood	O	NOUN	B
.	O	PUNCT	O


Of	O	ADP	O
44	O	NUM	O
patients	O	NOUN	B
,	O	PUNCT	O
nine	O	NUM	O
(	O	PUNCT	O
20	O	NUM	O
%	O	NOUN	O
)	O	PUNCT	O
had	O	AUX	O
facial	B-Disease	ADJ	B
angiofibromas	I-Disease	NOUN	I
,	O	PUNCT	O
tumours	B-Disease	NOUN	B
primarily	O	ADV	O
occurring	O	VERB	O
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	O
tuberous	B-Disease	ADJ	B
sclerosis	I-Disease	NOUN	I
.	O	PUNCT	O


Immunohistochemically	O	ADV	B
,	O	PUNCT	O
expression	O	NOUN	B
of	O	ADP	O
AGA	O	NOUN	B
in	O	ADP	O
AGU	B-Disease	NOUN	B
patients	O	NOUN	B
mucosal	B-Disease	ADJ	B
lesions	I-Disease	NOUN	I
did	O	AUX	O
not	O	PART	O
differ	O	VERB	O
from	O	ADP	O
that	O	DET	O
seen	O	VERB	O
in	O	ADP	O
corresponding	O	ADJ	O
lesions	O	NOUN	B
of	O	ADP	O
normal	O	ADJ	B
subjects	O	NOUN	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
germline	O	NOUN	B
mosaicism	O	NOUN	O
in	O	ADP	O
families	O	NOUN	B
with	O	ADP	O
Lowe	B-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
identification	O	NOUN	B
of	O	ADP	O
seven	O	NUM	O
novel	O	ADJ	B
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
OCRL1	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
examined	O	VERB	O
the	O	DET	O
OCRL1	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
eight	O	NUM	O
unrelated	O	ADJ	O
patients	O	NOUN	B
with	O	ADP	O
OCRL	B-Disease	NOUN	B
and	O	CCONJ	O
have	O	AUX	O
found	O	VERB	O
seven	O	NUM	O
new	O	ADJ	O
mutations	O	NOUN	B
and	O	CCONJ	O
one	O	NUM	O
recurrent	O	ADJ	B
in	O	ADP	O
-	O	PUNCT	O
frame	O	NOUN	B
deletion	O	NOUN	B
.	O	PUNCT	O


MEFV	O	NOUN	B
-	O	PUNCT	O
Gene	O	NOUN	B
analysis	O	NOUN	I
in	O	ADP	O
armenian	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
Familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	I
fever	I-Disease	NOUN	I
:	O	PUNCT	O
diagnostic	O	ADJ	B
value	O	NOUN	I
and	O	CCONJ	O
unfavorable	O	ADJ	B
renal	O	ADJ	B
prognosis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
M694V	O	NOUN	B
homozygous	O	ADJ	B
genotype	O	NOUN	B
-	O	PUNCT	O
genetic	O	ADJ	B
and	O	CCONJ	O
therapeutic	O	ADJ	B
implications	O	NOUN	B
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
Mediterranean	I-Disease	ADJ	I
fever	I-Disease	NOUN	I
(	O	PUNCT	O
FMF	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
a	O	DET	O
recessively	B-Disease	ADV	O
inherited	I-Disease	VERB	B
disorder	I-Disease	NOUN	O
that	O	PRON	O
is	O	AUX	O
common	O	ADJ	O
in	O	ADP	O
patients	O	NOUN	B
of	O	ADP	O
Armenian	O	ADJ	B
ancestry	O	NOUN	B
.	O	PUNCT	O


Renal	B-Disease	ADJ	B
amyloidosis	I-Disease	NOUN	I
,	O	PUNCT	O
prevented	O	VERB	B
by	O	ADP	O
colchicine	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
severe	O	ADJ	B
complication	O	NOUN	B
of	O	ADP	O
FMF	B-Disease	NOUN	B
,	O	PUNCT	O
a	O	DET	O
disorder	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
MEFV	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
M694V	O	NOUN	B
homozygous	O	ADJ	B
genotype	O	NOUN	B
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
higher	O	ADJ	O
prevalence	O	NOUN	B
of	O	ADP	O
renal	B-Disease	ADJ	B
amyloidosis	I-Disease	NOUN	I
and	O	CCONJ	O
arthritis	B-Disease	NOUN	B
,	O	PUNCT	O
compared	O	VERB	B
with	O	ADP	O
other	O	ADJ	O
genotypes	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
=	O	ADJ	O
.	O	PUNCT	O
0002	O	NUM	O
and	O	CCONJ	O
P	O	NOUN	O
=	O	ADJ	O
.	O	PUNCT	O
006	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Noninvasive	O	ADJ	B
test	O	NOUN	I
for	O	ADP	O
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
using	O	VERB	O
hair	O	NOUN	B
root	O	NOUN	I
analysis	O	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
a	O	DET	O
new	O	ADJ	O
diagnostic	O	ADJ	B
test	O	NOUN	I
to	O	PART	O
identify	O	VERB	O
male	O	ADJ	B
patients	O	NOUN	B
with	O	ADP	O
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
lack	O	NOUN	B
of	O	ADP	O
FMRP	O	NOUN	B
in	O	ADP	O
their	O	PRON	O
hair	O	NOUN	B
roots	O	NOUN	I
.	O	PUNCT	O


Expression	O	NOUN	B
of	O	ADP	O
FMRP	O	NOUN	B
in	O	ADP	O
hair	O	NOUN	B
roots	O	NOUN	I
was	O	AUX	O
studied	O	VERB	O
by	O	ADP	O
use	O	NOUN	O
of	O	ADP	O
an	O	DET	O
FMRP	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
antibody	O	NOUN	B
test	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
percentage	O	NOUN	B
of	O	ADP	O
FMRP	O	NOUN	B
-	O	PUNCT	O
expressing	O	VERB	B
hair	O	NOUN	B
roots	O	NOUN	I
in	O	ADP	O
controls	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
male	O	NOUN	B
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
patients	O	NOUN	B
was	O	AUX	O
determined	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
advantages	O	NOUN	O
of	O	ADP	O
this	O	DET	O
test	O	NOUN	B
are	O	AUX	O
(	O	PUNCT	O
1	O	X	O
)	O	PUNCT	O
plucking	O	NOUN	B
of	O	ADP	O
hair	O	NOUN	B
follicles	O	NOUN	I
does	O	AUX	O
no	O	DET	O
appreciable	O	ADJ	O
harm	O	NOUN	O
to	O	ADP	O
the	O	DET	O
mentally	B-Disease	ADV	B
retarded	I-Disease	VERB	B
patient	O	NOUN	B
,	O	PUNCT	O
(	O	PUNCT	O
2	O	X	O
)	O	PUNCT	O
hairs	O	NOUN	B
can	O	AUX	O
be	O	AUX	O
sent	O	VERB	O
in	O	ADP	O
a	O	DET	O
simple	O	ADJ	O
envelope	O	NOUN	O
to	O	PART	O
a	O	DET	O
diagnostic	O	ADJ	B
center	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
(	O	PUNCT	O
3	O	X	O
)	O	PUNCT	O
the	O	DET	O
result	O	NOUN	O
of	O	ADP	O
the	O	DET	O
test	O	NOUN	B
is	O	AUX	O
available	O	ADJ	O
within	O	ADP	O
5	O	NUM	O
h	O	NOUN	O
of	O	ADP	O
plucking	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
this	O	DET	O
test	O	NOUN	B
enabled	O	VERB	O
us	O	PRON	O
to	O	PART	O
identify	O	VERB	O
two	O	NUM	O
fragile	B-Disease	ADJ	B
X	I-Disease	NOUN	I
patients	O	NOUN	B
who	O	PRON	O
did	O	AUX	O
not	O	PART	O
show	O	VERB	O
the	O	DET	O
full	O	ADJ	O
mutation	O	NOUN	B
by	O	ADP	O
analysis	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
isolated	O	VERB	B
from	O	ADP	O
blood	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
previously	O	ADV	O
reported	O	VERB	O
evidence	O	NOUN	B
of	O	ADP	O
linkage	O	NOUN	B
to	O	PART	O
the	O	DET	O
1q24	O	NOUN	B
-	O	PUNCT	O
25	O	NUM	O
region	O	NOUN	B
(	O	PUNCT	O
HPC1	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
91	O	NUM	O
North	O	ADJ	B
American	O	ADJ	I
and	O	CCONJ	O
Swedish	O	ADJ	B
families	O	NOUN	B
each	O	DET	O
with	O	ADP	O
multiple	O	ADJ	B
cases	O	NOUN	B
of	O	ADP	O
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
(	O	PUNCT	O
Smith	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
1996	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
the	O	DET	O
present	O	ADJ	O
report	O	NOUN	B
we	O	PRON	O
analyze	O	VERB	B
40	O	NUM	O
(	O	PUNCT	O
12	O	NUM	O
original	O	ADJ	B
and	O	CCONJ	O
28	O	NUM	O
newly	O	ADV	O
identified	O	VERB	B
)	O	PUNCT	O
Swedish	O	ADJ	B
families	O	NOUN	B
with	O	ADP	O
hereditary	B-Disease	ADJ	B
prostate	I-Disease	NOUN	I
cancer	I-Disease	NOUN	I
(	O	PUNCT	O
HPC	B-Disease	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
,	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
40	O	NUM	O
markers	O	NOUN	B
spanning	O	VERB	O
a	O	DET	O
25	O	NUM	O
-	O	PUNCT	O
cM	O	NOUN	B
interval	O	NOUN	B
within	O	ADP	O
1q24	O	NOUN	B
-	O	PUNCT	O
25	O	NUM	O
,	O	PUNCT	O
have	O	AUX	O
evidence	O	NOUN	B
of	O	ADP	O
linkage	O	NOUN	B
.	O	PUNCT	O


Molecular	O	ADJ	B
basis	O	NOUN	I
of	O	ADP	O
feline	O	ADJ	B
beta	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
glucuronidase	I-Disease	NOUN	B
deficiency	I-Disease	NOUN	B
:	O	PUNCT	O
an	O	DET	O
animal	O	NOUN	B
model	O	NOUN	I
of	O	ADP	O
mucopolysaccharidosis	B-Disease	NOUN	B
VII	I-Disease	NOUN	I
.	O	PUNCT	O


Carriers	O	NOUN	B
identified	O	VERB	B
in	O	ADP	O
this	O	DET	O
manner	O	NOUN	O
produced	O	VERB	O
affected	O	VERB	B
kittens	O	NOUN	B
in	O	ADP	O
prospective	O	ADJ	B
breedings	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
feline	O	NOUN	B
MPS	B-Disease	NOUN	B
VII	I-Disease	NOUN	O
breeding	O	NOUN	B
colony	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
established	O	VERB	O
.	O	PUNCT	O
.	O	PUNCT	O


Three	O	NUM	O
congenital	B-Disease	ADJ	B
anomaly	I-Disease	NOUN	I
disorders	I-Disease	NOUN	I
,	O	PUNCT	O
cat	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
eye	I-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
,	O	PUNCT	O
der	B-Disease	NOUN	B
(	I-Disease	PUNCT	O
)	I-Disease	PUNCT	O
syndrome	I-Disease	NOUN	O
and	O	CCONJ	O
velo	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
cardio	I-Disease	NOUN	B
-	I-Disease	PUNCT	O
facial	I-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
/	O	SYM	O
DiGeorge	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
VCFS	B-Disease	NOUN	B
/	O	SYM	O
DGS	B-Disease	PROPN	B
)	O	PUNCT	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
tetrasomy	O	NOUN	B
,	O	PUNCT	O
trisomy	O	NOUN	B
or	O	CCONJ	O
monosomy	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
for	O	ADP	O
part	O	NOUN	O
of	O	ADP	O
chromosome	O	NOUN	O
22q11	O	NOUN	O
.	O	PUNCT	O


VCFS	B-Disease	NOUN	B
/	O	SYM	O
DGS	B-Disease	PROPN	B
is	O	AUX	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
syndrome	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
22q11	O	NOUN	B
rearrangements	O	NOUN	I
.	O	PUNCT	O


To	O	PART	O
investigate	O	VERB	B
this	O	DET	O
hypothesis	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
developed	O	VERB	O
hamster	O	NOUN	B
-	O	PUNCT	O
human	O	ADJ	B
somatic	O	ADJ	B
hybrid	O	NOUN	O
cell	O	NOUN	O
lines	O	NOUN	O
from	O	ADP	O
VCFS	B-Disease	PROPN	B
/	O	SYM	O
DGS	B-Disease	PROPN	B
patients	O	NOUN	B
with	O	ADP	O
all	O	DET	O
three	O	NUM	O
classes	O	NOUN	B
of	O	ADP	O
deletions	O	NOUN	B
and	O	CCONJ	O
we	O	PRON	O
now	O	ADV	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
breakpoints	O	NOUN	B
occur	O	VERB	O
within	O	ADP	O
similar	O	ADJ	O
low	O	ADJ	B
copy	O	NOUN	B
repeats	O	NOUN	I
,	O	PUNCT	O
termed	O	VERB	O
LCR22s	O	ADJ	B
.	O	PUNCT	O


We	O	PRON	O
present	O	VERB	O
models	O	NOUN	B
to	O	PART	O
explain	O	VERB	O
how	O	SCONJ	O
the	O	DET	O
LCR22s	O	NOUN	B
can	O	AUX	O
mediate	O	VERB	O
different	O	ADJ	O
homologous	O	ADJ	B
recombination	O	NOUN	I
events	O	NOUN	O
,	O	PUNCT	O
thereby	O	ADV	O
generating	O	VERB	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
rearrangements	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
congenital	B-Disease	ADJ	B
anomaly	I-Disease	NOUN	I
disorders	I-Disease	NOUN	I
.	O	PUNCT	O


Functional	O	ADJ	B
consequences	O	NOUN	B
of	O	ADP	I
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
early	O	ADJ	B
growth	O	NOUN	B
response	O	NOUN	I
2	O	NUM	I
gene	O	NOUN	I
(	O	PUNCT	O
EGR2	O	NOUN	B
)	O	PUNCT	O
correlate	O	VERB	B
with	O	ADP	O
severity	O	NOUN	B
of	O	ADP	O
human	O	ADJ	B
myelinopathies	B-Disease	NOUN	B
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
EGR2	O	NOUN	O
gene	O	NOUN	O
have	O	AUX	O
recently	O	ADV	O
been	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
the	O	DET	O
inherited	B-Disease	VERB	B
peripheral	I-Disease	ADJ	B
neuropathies	I-Disease	NOUN	I
Charcot	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Marie	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Tooth	I-Disease	PROPN	B
type	I-Disease	NOUN	I
1	I-Disease	NUM	I
,	O	PUNCT	O
Dejerine	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Sottas	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
and	O	CCONJ	O
congenital	B-Disease	ADJ	B
hypomyelinating	I-Disease	ADJ	I
neuropathy	I-Disease	NOUN	I
.	O	PUNCT	O


Familial	B-Disease	ADJ	B
neurohypophyseal	I-Disease	ADJ	B
diabetes	I-Disease	NOUN	I
insipidus	I-Disease	NOUN	B
is	O	AUX	O
an	O	DET	O
autosomal	B-Disease	ADJ	B
dominant	I-Disease	ADJ	O
disorder	I-Disease	NOUN	O
characterized	O	VERB	B
by	O	ADP	O
post	O	NOUN	B
-	O	PUNCT	O
natal	O	NOUN	B
development	O	NOUN	B
of	O	ADP	O
arginine	B-Disease	NOUN	B
vasopressin	I-Disease	NOUN	I
(	I-Disease	PUNCT	I
AVP	I-Disease	NOUN	B
)	I-Disease	PUNCT	O
deficiency	I-Disease	NOUN	B
due	O	ADP	O
to	O	PART	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
AVP	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
studied	O	VERB	O
an	O	DET	O
unusual	O	ADJ	O
Palestinian	O	ADJ	B
family	O	NOUN	O
consisting	O	VERB	O
of	O	ADP	O
asymptomatic	O	ADJ	B
first	O	ADJ	B
cousin	O	NOUN	I
parents	O	NOUN	B
and	O	CCONJ	O
three	O	NUM	O
children	O	NOUN	B
affected	O	VERB	B
with	O	ADP	O
neurohypophyseal	B-Disease	ADJ	B
diabetes	I-Disease	NOUN	I
insipidus	I-Disease	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
autosomal	O	ADJ	B
recessive	O	ADJ	I
inheritance	O	NOUN	B
.	O	PUNCT	O


No	O	DET	O
inherited	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
GPI	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
anchor	I-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
has	O	AUX	O
been	O	AUX	O
described	O	VERB	O
.	O	PUNCT	O


Because	O	SCONJ	O
conventional	O	ADJ	O
Piga	O	NOUN	B
gene	O	NOUN	I
knockout	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
high	O	ADJ	O
embryonic	B-Disease	ADJ	O
lethality	I-Disease	NOUN	O
in	O	ADP	O
chimeric	O	ADJ	B
mice	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
used	O	VERB	O
the	O	DET	O
Cre	O	PROPN	B
/	O	SYM	O
loxP	O	NOUN	B
system	O	NOUN	O
.	O	PUNCT	O


Targeted	O	VERB	B
mutagenesis	O	NOUN	I
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
produce	O	VERB	O
two	O	NUM	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
murine	O	ADJ	B
hemochromatosis	B-Disease	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
Hfe	O	NOUN	B
)	O	PUNCT	O
locus	O	NOUN	B
.	O	PUNCT	O


Genotype	O	ADJ	B
-	O	PUNCT	O
phenotype	O	NOUN	B
analysis	O	NOUN	B
in	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
Emery	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
and	O	CCONJ	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
missense	O	NOUN	B
mutation	O	NOUN	I
associated	O	VERB	B
with	O	ADP	I
a	O	DET	O
milder	O	ADJ	B
phenotype	O	NOUN	B
.	O	PUNCT	O


Age	O	NOUN	B
at	O	ADP	O
onset	O	NOUN	O
was	O	AUX	O
later	O	ADV	O
for	O	ADP	O
first	O	ADJ	O
symptoms	O	NOUN	B
and	O	CCONJ	O
for	O	ADP	O
development	O	NOUN	B
of	O	ADP	O
ankle	B-Disease	NOUN	B
contractures	I-Disease	NOUN	I
and	O	CCONJ	O
muscle	B-Disease	NOUN	B
weakness	I-Disease	NOUN	I
.	O	PUNCT	O


Severe	O	ADJ	B
clinical	O	ADJ	B
expression	O	NOUN	I
in	O	ADP	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
Emery	I-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
.	O	PUNCT	O


The	O	DET	O
interfamilial	O	ADJ	B
heterogeneity	O	NOUN	B
in	O	ADP	O
distribution	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
severity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
features	O	NOUN	B
in	O	ADP	O
the	O	DET	O
two	O	NUM	O
families	O	NOUN	B
point	O	VERB	O
to	O	ADP	O
environmental	O	ADJ	B
or	O	CCONJ	O
genetic	O	ADJ	B
modification	O	NOUN	I
as	O	ADP	O
the	O	DET	O
cause	O	NOUN	O
of	O	ADP	O
clinical	O	ADJ	B
variability	O	NOUN	B
in	O	ADP	O
Emery	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Dreifuss	I-Disease	PROPN	B
muscular	I-Disease	ADJ	B
dystrophy	I-Disease	NOUN	I
.	O	PUNCT	O
.	O	PUNCT	O


Common	O	ADJ	B
mutations	O	NOUN	B
in	O	ADP	O
BRCA1	O	NOUN	B
and	O	CCONJ	O
BRCA2	O	NOUN	B
do	O	AUX	O
not	O	PART	O
contribute	O	VERB	O
to	O	PART	O
early	O	ADJ	B
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
in	O	ADP	O
Jewish	O	ADJ	B
men	O	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
We	O	PRON	O
examined	O	VERB	O
genomic	O	ADJ	B
DNA	O	NOUN	I
from	O	ADP	O
83	O	NUM	O
(	O	PUNCT	O
for	O	ADP	O
BRCA1	O	NOUN	B
185delAG	O	NOUN	O
)	O	PUNCT	O
or	O	CCONJ	O
82	O	NUM	O
(	O	PUNCT	O
for	O	ADP	O
BRCA2	O	NOUN	B
6174delT	O	NOUN	I
)	O	PUNCT	O
Ashkenazi	O	ADJ	B
Jewish	O	ADJ	B
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
patients	O	NOUN	B
,	O	PUNCT	O
most	O	ADJ	O
of	O	ADP	O
whom	O	PRON	O
were	O	AUX	O
treated	O	VERB	B
at	O	ADP	O
a	O	DET	O
relatively	O	ADV	O
young	O	ADJ	B
age	O	NOUN	B
,	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
most	O	ADV	O
common	O	ADJ	O
germline	O	NOUN	B
mutation	O	NOUN	I
in	O	ADP	O
each	O	DET	O
gene	O	NOUN	B
seen	O	VERB	O
in	O	ADP	O
the	O	DET	O
Ashkenazi	O	ADJ	B
population	O	NOUN	B
.	O	PUNCT	O


RESULTS	O	VERB	B
Our	O	PRON	O
study	O	NOUN	B
should	O	AUX	O
have	O	AUX	O
been	O	AUX	O
able	O	ADJ	O
to	O	PART	O
detect	O	VERB	B
a	O	DET	O
4	O	NUM	O
-	O	PUNCT	O
5	O	NUM	O
-	O	PUNCT	O
fold	O	ADJ	B
increase	O	NOUN	B
in	O	ADP	O
the	O	DET	O
risk	O	NOUN	B
of	O	ADP	O
prostate	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
due	O	ADP	O
to	O	PART	O
mutation	O	NOUN	B
of	O	ADP	O
BRCA1	O	NOUN	B
or	O	CCONJ	O
BRCA2	O	NOUN	B
.	O	PUNCT	O


Beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
accumulation	O	NOUN	B
and	O	CCONJ	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CTNNB1	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
hepatoblastoma	B-Disease	NOUN	B
.	O	PUNCT	O


Epidemiologic	O	ADJ	B
studies	O	NOUN	I
have	O	AUX	O
shown	O	VERB	O
an	O	DET	O
increased	O	VERB	B
frequency	O	NOUN	B
of	O	ADP	O
this	O	DET	O
tumor	B-Disease	NOUN	B
type	O	NOUN	I
in	O	ADP	O
families	O	NOUN	B
affected	O	VERB	B
by	O	ADP	O
adenomatous	B-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
coli	I-Disease	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
an	O	DET	O
ongoing	O	ADJ	O
immunohistochemical	O	ADJ	B
study	O	NOUN	I
of	O	ADP	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
sporadic	O	ADJ	B
cases	O	NOUN	B
of	O	ADP	O
tumor	B-Disease	NOUN	B
types	O	NOUN	I
that	O	PRON	O
are	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
adenomatous	B-Disease	ADJ	B
polyposis	I-Disease	NOUN	I
coli	I-Disease	X	I
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
increased	O	VERB	B
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
the	O	DET	O
cytoplasm	O	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
nuclei	O	NOUN	B
of	O	ADP	O
three	O	NUM	O
investigated	O	VERB	B
hepatoblastomas	B-Disease	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
data	O	NOUN	B
indicate	O	VERB	O
for	O	ADP	O
the	O	DET	O
first	O	ADJ	O
time	O	NOUN	O
that	O	SCONJ	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
accumulation	O	NOUN	B
may	O	AUX	O
play	O	VERB	O
a	O	DET	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
hepatoblastoma	B-Disease	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
activating	O	VERB	B
mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
beta	O	NOUN	B
-	O	PUNCT	O
catenin	O	NOUN	B
gene	O	NOUN	B
may	O	AUX	O
substitute	O	VERB	O
biallelic	O	ADJ	B
APC	O	NOUN	B
inactivation	O	NOUN	B
in	O	ADP	O
this	O	DET	O
tumor	B-Disease	NOUN	B
type	O	NOUN	I
.	O	PUNCT	O


Hereditary	B-Disease	ADJ	B
progressive	I-Disease	ADJ	I
dystonia	I-Disease	NOUN	I
with	O	ADP	O
marked	O	ADJ	O
diurnal	O	ADJ	B
fluctuation	O	NOUN	O
(	O	PUNCT	O
HPD	B-Disease	NOUN	B
;	O	PUNCT	O
dopa	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
responsive	I-Disease	ADJ	B
dystonia	I-Disease	NOUN	B
,	O	PUNCT	O
DRD	B-Disease	NOUN	B
)	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
recently	O	ADV	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
a	O	DET	O
genetic	B-Disease	ADJ	B
defect	I-Disease	NOUN	I
in	O	ADP	O
the	O	DET	O
GTP	O	NOUN	B
cyclohydrolase	O	NOUN	I
I	O	NUM	I
(	O	PUNCT	O
GCH1	O	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	O
.	O	PUNCT	O


Sulfate	O	NOUN	B
transport	O	NOUN	I
is	O	AUX	O
not	O	PART	O
impaired	O	ADJ	B
in	O	ADP	O
pendred	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
thyrocytes	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
gene	O	NOUN	B
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
(	O	PUNCT	O
PDS	B-Disease	PROPN	B
)	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
cloned	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
its	O	PRON	O
function	O	NOUN	B
is	O	AUX	O
as	O	ADP	O
yet	O	ADV	O
unknown	O	ADJ	B
and	O	CCONJ	O
the	O	DET	O
connection	O	NOUN	B
between	O	ADP	O
thyroid	B-Disease	NOUN	B
goiter	I-Disease	NOUN	I
and	O	CCONJ	O
sensory	B-Disease	ADJ	B
-	I-Disease	PUNCT	O
neural	I-Disease	ADJ	B
deafness	I-Disease	NOUN	I
remains	O	VERB	O
an	O	DET	O
enigma	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
tested	O	VERB	B
sulfate	O	NOUN	B
transport	O	NOUN	I
in	O	ADP	O
thyrocytes	O	NOUN	B
obtained	O	VERB	O
from	O	ADP	O
Pendred	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
patients	O	NOUN	B
and	O	CCONJ	O
found	O	VERB	O
that	O	SCONJ	O
it	O	PRON	O
was	O	AUX	O
not	O	PART	O
defective	O	ADJ	B
.	O	PUNCT	O


Mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
gene	O	NOUN	B
that	O	PRON	O
encodes	O	VERB	B
type	O	NOUN	B
II	O	NUM	I
collagen	O	NOUN	I
(	O	PUNCT	O
COL2A1	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
predominant	O	ADJ	O
protein	O	NOUN	B
of	O	ADP	O
cartilage	O	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
identified	O	VERB	B
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
individuals	O	NOUN	B
with	O	ADP	O
Kniest	B-Disease	NOUN	B
dysplasia	I-Disease	NOUN	I
.	O	PUNCT	O


Sequencing	O	NOUN	B
of	O	ADP	O
the	O	DET	O
index	O	NOUN	O
patients	O	NOUN	B
genomic	O	ADJ	B
DNA	O	NOUN	I
identified	O	VERB	O
four	O	NUM	O
new	O	ADJ	O
dominant	O	ADJ	B
mutations	O	NOUN	B
in	O	ADP	O
COL2A1	O	NOUN	B
that	O	PRON	O
result	O	VERB	O
in	O	ADP	O
Kniest	B-Disease	NOUN	B
dysplasia	I-Disease	NOUN	I
a	O	DET	O
21	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
deletion	O	NOUN	B
in	O	ADP	O
exon	O	NOUN	B
16	O	NUM	O
,	O	PUNCT	O
an	O	DET	O
18	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
deletion	O	NOUN	B
in	O	ADP	O
exon	O	NOUN	B
19	O	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
4	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
deletions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
splice	O	NOUN	B
donor	O	NOUN	I
sites	O	NOUN	I
of	O	ADP	O
introns	O	NOUN	B
14	O	NUM	O
and	O	CCONJ	O
20	O	NUM	O
.	O	PUNCT	O


Classical	B-Disease	ADJ	O
galactosemia	I-Disease	NOUN	B
and	O	CCONJ	O
mutations	O	NOUN	B
at	O	ADP	O
the	O	DET	O
galactose	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
-	O	PUNCT	O
phosphate	O	NOUN	B
uridyl	O	ADJ	I
transferase	O	NOUN	I
(	O	PUNCT	O
GALT	O	NOUN	B
)	O	PUNCT	O
gene	O	NOUN	O
.	O	PUNCT	O


Classical	B-Disease	ADJ	O
galactosemia	I-Disease	NOUN	B
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
a	O	DET	O
deficiency	O	NOUN	B
in	O	ADP	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
enzyme	O	NOUN	B
galactose	O	NOUN	I
-	O	PUNCT	O
1	O	NUM	B
-	O	PUNCT	O
phosphate	O	NOUN	B
uridyl	O	ADJ	I
transferase	O	NOUN	I
(	O	PUNCT	O
GALT	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
,	O	PUNCT	O
in	O	ADP	O
turn	O	NOUN	O
,	O	PUNCT	O
is	O	AUX	O
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
at	O	ADP	O
the	O	DET	O
GALT	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Mutations	O	NOUN	B
of	O	ADP	O
the	O	DET	O
VHL	B-Disease	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
sporadic	B-Disease	ADJ	B
renal	I-Disease	ADJ	I
cell	I-Disease	NOUN	I
carcinoma	I-Disease	NOUN	I
:	O	PUNCT	O
definition	O	NOUN	B
of	O	ADP	O
a	O	DET	O
risk	O	NOUN	B
factor	O	NOUN	I
for	O	ADP	O
VHL	B-Disease	NOUN	B
patients	O	NOUN	B
to	O	PART	O
develop	O	VERB	O
an	O	DET	O
RCC	B-Disease	NOUN	B
.	O	PUNCT	O


VHL	B-Disease	NOUN	B
mutations	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
only	O	ADV	O
in	O	ADP	O
the	O	DET	O
nonpapillary	B-Disease	ADJ	B
renal	I-Disease	ADJ	I
cell	I-Disease	NOUN	I
carcinoma	I-Disease	NOUN	I
(	O	PUNCT	O
RCC	B-Disease	NOUN	B
)	O	PUNCT	O
subtype	O	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
previously	O	ADV	O
reported	O	VERB	O
.	O	PUNCT	O


We	O	PRON	O
postulated	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
specific	O	ADJ	O
pattern	O	NOUN	B
of	O	ADP	O
VHL	B-Disease	NOUN	B
mutations	O	NOUN	B
is	O	AUX	O
associated	O	VERB	B
with	O	ADP	I
sporadic	B-Disease	ADJ	B
RCC	I-Disease	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
observed	O	VERB	O
RCC	B-Disease	NOUN	B
in	O	ADP	O
at	O	ADP	O
least	O	ADJ	O
one	O	NUM	O
member	O	NOUN	O
of	O	ADP	O
the	O	DET	O
VHL	B-Disease	NOUN	B
families	O	NOUN	B
in	O	ADP	O
77	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
cases	O	NOUN	B
with	O	ADP	O
mutations	O	NOUN	B
leading	O	VERB	O
to	O	PART	O
truncated	O	VERB	B
proteins	O	NOUN	I
versus	O	CCONJ	O
55	O	NUM	O
%	O	NOUN	O
in	O	ADP	O
cases	O	NOUN	B
with	O	ADP	O
missense	O	NOUN	B
mutations	O	NOUN	I
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


Chediak	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
Higashi	I-Disease	PROPN	B
syndrome	I-Disease	NOUN	I
(	O	PUNCT	O
CHS	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
inherited	B-Disease	VERB	B
disorder	I-Disease	NOUN	I
caused	O	VERB	O
by	O	ADP	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
lysosomal	O	ADJ	B
trafficking	O	NOUN	I
regulator	O	NOUN	I
gene	O	NOUN	I
,	O	PUNCT	O
LYST	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
murine	O	ADJ	B
equivalent	O	NOUN	B
of	O	ADP	O
CHS	B-Disease	NOUN	B
,	O	PUNCT	O
beige	O	NOUN	B
mice	O	NOUN	I
,	O	PUNCT	O
present	O	VERB	O
similar	O	ADJ	O
characteristics	O	NOUN	B
but	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
develop	O	VERB	O
the	O	DET	O
lymphoproliferative	B-Disease	ADJ	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
therefore	O	ADV	O
proposed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
defective	O	ADJ	B
surface	O	NOUN	B
expression	O	NOUN	B
of	O	ADP	O
CTLA	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	O
by	O	ADP	O
CHS	B-Disease	NOUN	B
T	O	NOUN	B
cells	O	NOUN	I
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
generation	O	NOUN	B
of	O	ADP	O
lymphoproliferative	B-Disease	ADJ	B
disease	I-Disease	NOUN	I
.	O	PUNCT	O


Proteolipoprotein	O	ADJ	B
gene	O	NOUN	I
analysis	O	NOUN	I
in	O	ADP	O
82	O	NUM	O
patients	O	NOUN	B
with	O	ADP	O
sporadic	O	ADJ	B
Pelizaeus	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Merzbacher	I-Disease	PROPN	B
Disease	I-Disease	PROPN	I
:	O	PUNCT	O
duplications	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
major	O	ADJ	O
cause	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
,	O	PUNCT	O
originate	O	VERB	O
more	O	ADV	O
frequently	O	ADV	O
in	O	ADP	O
male	O	ADJ	B
germ	O	NOUN	B
cells	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
point	O	NOUN	O
mutations	O	NOUN	B
do	O	AUX	O
not	O	PART	O
.	O	PUNCT	O


Pelizaeus	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Merzbacher	I-Disease	PROPN	B
Disease	I-Disease	PROPN	I
(	O	PUNCT	O
PMD	B-Disease	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
an	O	DET	O
X	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
linked	I-Disease	VERB	B
developmental	I-Disease	ADJ	B
defect	I-Disease	NOUN	O
of	I-Disease	ADP	O
myelination	I-Disease	NOUN	B
affecting	O	VERB	B
the	O	DET	O
central	O	ADJ	B
nervous	O	ADJ	I
system	O	NOUN	I
and	O	CCONJ	O
segregating	O	VERB	B
with	O	ADP	O
the	O	DET	O
proteolipoprotein	O	NOUN	B
(	O	PUNCT	O
PLP	O	NOUN	B
)	O	PUNCT	O
locus	O	NOUN	B
.	O	PUNCT	O


Chromosome	O	NOUN	B
breakage	O	NOUN	I
in	O	ADP	O
the	O	DET	O
Prader	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
and	I-Disease	CCONJ	O
Angelman	I-Disease	ADJ	B
syndromes	I-Disease	NOUN	I
involves	O	VERB	O
recombination	O	NOUN	B
between	O	ADP	O
large	O	ADJ	O
,	O	PUNCT	O
transcribed	O	VERB	B
repeats	O	NOUN	I
at	O	ADP	O
proximal	O	ADJ	B
and	O	CCONJ	O
distal	O	ADJ	B
breakpoints	O	NOUN	I
.	O	PUNCT	O


Linkage	O	NOUN	B
analysis	O	NOUN	I
in	O	ADP	O
a	O	DET	O
large	O	ADJ	O
Brazilian	O	ADJ	B
family	O	NOUN	O
with	O	ADP	O
van	B-Disease	X	B
der	I-Disease	NOUN	I
Woude	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
suggests	O	VERB	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
a	O	DET	O
susceptibility	O	NOUN	B
locus	O	NOUN	I
for	O	ADP	O
cleft	B-Disease	ADJ	B
palate	I-Disease	NOUN	I
at	O	ADP	I
17p11	O	NOUN	I
.	O	PUNCT	O
2	O	NUM	O
-	O	SYM	O
11	O	NUM	O
.	O	PUNCT	O
1	O	NUM	O
.	O	PUNCT	O


van	B-Disease	X	O
der	I-Disease	NOUN	O
Woude	I-Disease	NOUN	O
syndrome	I-Disease	NOUN	O
(	O	PUNCT	O
VWS	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
been	O	AUX	O
mapped	O	VERB	O
to	O	PART	O
1q32	O	NOUN	B
-	O	PUNCT	O
41	O	NUM	O
,	O	PUNCT	O
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
pits	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
/	I-Disease	SYM	O
or	I-Disease	CCONJ	O
sinuses	I-Disease	NOUN	B
of	I-Disease	ADP	O
the	I-Disease	DET	O
lower	I-Disease	ADJ	B
lip	I-Disease	NOUN	I
,	O	PUNCT	O
cleft	B-Disease	NOUN	B
lip	I-Disease	NOUN	I
/	I-Disease	PUNCT	O
palate	I-Disease	NOUN	B
(	O	PUNCT	O
CL	B-Disease	NOUN	B
/	I-Disease	SYM	O
P	I-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
cleft	B-Disease	ADJ	B
palate	I-Disease	NOUN	I
(	O	PUNCT	I
CP	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
bifid	B-Disease	NOUN	B
uvula	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
hypodontia	B-Disease	NOUN	B
(	O	PUNCT	O
H	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Both	O	CCONJ	O
the	O	DET	O
occurrence	O	NOUN	B
of	O	ADP	O
CL	B-Disease	NOUN	B
/	I-Disease	PUNCT	O
P	I-Disease	NOUN	B
and	O	CCONJ	O
CP	B-Disease	NOUN	B
within	O	ADP	O
the	O	DET	O
same	O	ADJ	O
genealogy	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
recurrence	O	NOUN	B
risk	O	NOUN	I
<	O	X	O
40	O	NUM	O
%	O	NOUN	O
for	O	ADP	O
CP	B-Disease	NOUN	B
among	O	ADP	O
descendants	O	NOUN	B
with	O	ADP	O
VWS	B-Disease	NOUN	B
have	O	AUX	O
suggested	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
clefts	B-Disease	NOUN	B
in	O	ADP	O
this	O	DET	O
syndrome	O	NOUN	B
is	O	AUX	O
influenced	O	VERB	B
by	O	ADP	O
modifying	O	VERB	O
genes	O	NOUN	B
at	O	ADP	O
other	O	ADJ	O
loci	O	NOUN	B
.	O	PUNCT	O


1	O	NUM	O
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
the	O	DET	O
VWS	B-Disease	NOUN	B
gene	O	NOUN	I
at	O	ADP	O
1p32	O	NOUN	B
-	O	PUNCT	O
41	O	NUM	O
,	O	PUNCT	O
enhances	O	VERB	B
the	O	DET	O
probability	O	NOUN	B
of	O	ADP	O
CP	B-Disease	NOUN	B
in	O	ADP	O
an	O	DET	O
individual	O	NOUN	B
carrying	O	VERB	O
the	O	DET	O
two	O	NUM	O
at	O	ADP	O
-	O	PUNCT	O
risk	O	NOUN	B
genes	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
DNA	O	NOUN	B
as	O	ADP	O
the	O	DET	O
starting	O	NOUN	O
material	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
screened	O	VERB	B
the	O	DET	O
ATM	O	NOUN	B
gene	O	NOUN	I
in	O	ADP	O
92	O	NUM	O
A	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
T	I-Disease	NOUN	B
patients	O	NOUN	B
,	O	PUNCT	O
using	O	VERB	O
an	O	DET	O
optimized	O	ADJ	B
single	O	ADJ	B
-	O	PUNCT	O
strand	O	NOUN	B
conformation	O	NOUN	O
polymorphism	O	NOUN	O
(	O	PUNCT	O
SSCP	O	NOUN	B
)	O	PUNCT	O
technique	O	NOUN	O
that	O	PRON	O
detected	O	VERB	B
all	O	DET	O
previously	O	ADV	O
known	O	VERB	O
mutations	O	NOUN	B
in	O	ADP	O
the	O	DET	O
polymerase	O	NOUN	B
chain	O	NOUN	I
reaction	O	NOUN	I
(	O	PUNCT	O
PCR	O	NOUN	B
)	O	PUNCT	O
segments	O	NOUN	B
being	O	AUX	O
analyzed	O	VERB	B
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
mutation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
XK	O	NOUN	B
gene	O	NOUN	I
(	O	PUNCT	O
XK	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
Japanese	O	ADJ	B
patient	O	NOUN	B
with	O	ADP	O
McLeod	B-Disease	NOUN	B
syndrome	I-Disease	NOUN	I
.	O	PUNCT	O


A	O	DET	O
50	O	NUM	O
-	O	PUNCT	O
year	O	NOUN	B
-	O	PUNCT	O
old	O	ADJ	B
man	O	NOUN	B
showed	O	VERB	O
progressive	O	ADJ	B
muscular	B-Disease	ADJ	B
atrophy	I-Disease	NOUN	I
,	O	PUNCT	O
choreic	B-Disease	ADJ	B
movement	I-Disease	NOUN	B
,	O	PUNCT	O
elevated	O	ADJ	B
level	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
creatinine	O	NOUN	I
kinase	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
acanthocytosis	B-Disease	NOUN	B
.	O	PUNCT	O


Formation	O	NOUN	B
of	O	ADP	O
irradiation	O	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
foci	O	NOUN	B
positive	O	ADJ	B
for	O	ADP	O
BRCA1	O	NOUN	B
,	O	PUNCT	O
hRad50	O	ADJ	B
,	O	PUNCT	O
hMre11	O	NOUN	B
,	O	PUNCT	O
or	O	CCONJ	O
p95	O	NOUN	B
was	O	AUX	O
dramatically	O	ADV	O
reduced	O	VERB	B
in	O	ADP	O
HCC	O	NOUN	B
/	O	SYM	O
1937	O	NUM	B
breast	B-Disease	NOUN	I
cancer	I-Disease	NOUN	I
cells	O	NOUN	O
carrying	O	VERB	O
a	O	DET	O
homozygous	O	ADJ	B
mutation	O	NOUN	B
in	O	ADP	O
BRCA1	O	NOUN	B
but	O	CCONJ	O
was	O	AUX	O
restored	O	VERB	B
by	O	ADP	O
transfection	O	NOUN	B
of	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
BRCA1	O	NOUN	B
.	O	PUNCT	O


OBJECTIVE	O	NOUN	O
To	O	PART	O
examine	O	VERB	O
the	O	DET	O
relationship	O	NOUN	B
of	O	ADP	O
phenylalanine	O	NOUN	B
hydroxylase	O	NOUN	I
(	O	PUNCT	O
PAH	O	NOUN	B
)	O	PUNCT	O
genotypes	O	NOUN	B
to	O	PART	O
biochemical	O	ADJ	B
phenotype	O	NOUN	B
and	O	CCONJ	O
cognitive	O	ADJ	B
development	O	NOUN	I
in	O	ADP	O
maternal	B-Disease	ADJ	B
phenylketonuria	I-Disease	NOUN	I
(	O	PUNCT	O
PKU	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Based	O	VERB	O
on	O	ADP	O
previous	O	ADJ	O
knowledge	O	NOUN	B
about	O	ADP	O
mutation	O	NOUN	B
-	O	PUNCT	O
phenotype	O	NOUN	B
associations	O	NOUN	B
,	O	PUNCT	O
78	O	NUM	O
of	O	ADP	O
the	O	DET	O
mutations	O	NOUN	B
could	O	AUX	O
be	O	AUX	O
assigned	O	VERB	O
to	O	ADP	O
one	O	NUM	O
of	O	ADP	O
four	O	NUM	O
classes	O	NOUN	B
of	O	ADP	O
severity	O	NOUN	B
(	O	PUNCT	O
severe	O	ADJ	B
PKU	B-Disease	NOUN	B
,	O	PUNCT	O
moderate	O	ADJ	B
PKU	B-Disease	NOUN	B
,	O	PUNCT	O
mild	O	ADJ	B
PKU	B-Disease	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
mild	B-Disease	ADJ	B
hyperphenylalaninemia	I-Disease	NOUN	B
[	O	PUNCT	O
MHP	B-Disease	PROPN	B
]	O	PUNCT	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
IQ	O	NOUN	B
of	O	ADP	O
PAH	B-Disease	NOUN	B
-	I-Disease	PUNCT	O
deficient	I-Disease	ADJ	B
mothers	O	NOUN	B
with	O	ADP	O
a	O	DET	O
severe	O	ADJ	B
PKU	B-Disease	NOUN	B
mutation	O	NOUN	B
in	O	ADP	O
combination	O	NOUN	B
with	O	ADP	O
a	O	DET	O
MHP	B-Disease	NOUN	B
mutation	O	NOUN	B
or	O	CCONJ	O
a	O	DET	O
mild	O	ADJ	B
PKU	B-Disease	NOUN	B
mutation	O	NOUN	B
was	O	AUX	O
99	O	NUM	O
and	O	CCONJ	O
96	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
whereas	O	SCONJ	O
the	O	DET	O
IQ	O	NOUN	B
of	O	ADP	O
PKU	B-Disease	NOUN	B
mothers	O	NOUN	B
with	O	ADP	O
two	O	NUM	O
severe	O	ADJ	B
PKU	B-Disease	NOUN	B
mutations	O	NOUN	B
or	O	CCONJ	O
with	O	ADP	O
one	O	NUM	O
severe	O	ADJ	B
and	O	CCONJ	O
one	O	NUM	O
moderate	O	ADJ	B
PKU	B-Disease	NOUN	B
mutation	O	NOUN	B
was	O	AUX	O
83	O	NUM	O
and	O	CCONJ	O
84	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


CONCLUSIONS	O	NOUN	O
The	O	DET	O
reproductive	O	ADJ	B
outcome	O	NOUN	I
in	O	ADP	O
maternal	B-Disease	ADJ	B
phenylketonuria	I-Disease	NOUN	I
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
prenatal	O	ADJ	B
metabolic	O	ADJ	B
control	O	NOUN	I
and	O	CCONJ	O
postnatal	O	ADJ	B
environmental	O	ADJ	B
circumstances	O	NOUN	I
.	O	PUNCT	O


Both	O	DET	O
factors	O	NOUN	B
depend	O	VERB	O
on	O	ADP	O
the	O	DET	O
intellectual	O	ADJ	B
resources	O	NOUN	I
of	O	ADP	O
the	O	DET	O
mother	O	NOUN	B
with	O	ADP	O
PKU	B-Disease	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
seven	O	NUM	O
Dutch	O	ADJ	B
patients	O	NOUN	B
from	O	ADP	O
six	O	NUM	O
families	O	NOUN	B
with	O	ADP	O
a	O	DET	O
slowly	O	ADV	O
progressive	O	ADJ	B
,	O	PUNCT	O
mainly	O	ADV	O
spinal	B-Disease	ADJ	B
cord	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
that	O	PRON	O
remained	O	VERB	O
for	O	ADP	O
many	O	ADJ	O
years	O	NOUN	B
the	O	DET	O
sole	O	NOUN	O
expression	O	NOUN	B
of	O	ADP	O
cerebrotendinous	B-Disease	ADJ	B
xanthomatosis	I-Disease	NOUN	I
(	O	PUNCT	O
CTX	B-Disease	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


MRI	O	NOUN	B
demonstrated	O	VERB	O
white	B-Disease	ADJ	B
matter	I-Disease	NOUN	I
abnormalities	I-Disease	NOUN	B
in	O	ADP	O
the	O	DET	O
lateral	O	ADJ	B
and	O	CCONJ	O
dorsal	O	ADJ	B
columns	O	NOUN	I
of	O	ADP	O
the	O	DET	O
spinal	O	ADJ	B
cord	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
transgene	O	NOUN	B
insertion	O	NOUN	B
creating	O	VERB	O
a	O	DET	O
heritable	O	ADJ	B
chromosome	O	NOUN	B
deletion	O	NOUN	I
mouse	O	NOUN	I
model	O	NOUN	I
of	O	ADP	O
Prader	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Willi	I-Disease	PROPN	B
and	I-Disease	CCONJ	O
angelman	I-Disease	ADJ	B
syndromes	I-Disease	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
report	O	VERB	O
here	O	ADV	O
the	O	DET	O
characterization	O	NOUN	B
of	O	ADP	O
a	O	DET	O
transgene	O	NOUN	B
insertion	O	NOUN	I
(	O	PUNCT	O
Epstein	O	PROPN	B
-	O	PUNCT	O
Barr	O	PROPN	B
virus	O	NOUN	I
Latent	O	ADJ	B
Membrane	O	NOUN	I
Protein	O	NOUN	I
2A	O	NOUN	I
,	O	PUNCT	O
LMP2A	O	NOUN	B
)	O	PUNCT	O
into	O	ADP	O
mouse	O	NOUN	B
chromosome	O	NOUN	I
7C	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
has	O	AUX	O
resulted	O	VERB	O
in	O	ADP	O
mouse	O	NOUN	B
models	O	NOUN	I
for	O	ADP	O
PWS	B-Disease	NOUN	B
and	O	CCONJ	O
AS	B-Disease	NOUN	B
dependent	O	ADJ	B
on	O	ADP	O
the	O	DET	O
sex	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transmitting	O	VERB	B
parent	O	NOUN	B
.	O	PUNCT	O


Because	O	SCONJ	O
the	O	DET	O
intact	O	ADJ	B
chromosome	O	NOUN	O
7	O	NUM	O
,	O	PUNCT	O
opposite	O	ADJ	O
the	O	DET	O
deleted	O	VERB	B
homolog	O	NOUN	B
,	O	PUNCT	O
maintains	O	VERB	O
the	O	DET	O
correct	O	ADJ	O
imprint	O	NOUN	B
in	O	ADP	O
somatic	O	ADJ	B
cells	O	NOUN	I
of	O	ADP	O
PWS	B-Disease	NOUN	B
and	O	CCONJ	O
AS	B-Disease	ADJ	B
mice	O	NOUN	B
and	O	CCONJ	O
establishes	O	VERB	O
the	O	DET	O
correct	O	ADJ	O
imprint	O	NOUN	B
in	O	ADP	O
male	O	NOUN	B
and	O	CCONJ	O
female	O	ADJ	B
germ	O	NOUN	B
cells	O	NOUN	I
of	O	ADP	O
AS	B-Disease	ADJ	B
mice	O	NOUN	B
,	O	PUNCT	O
homologous	O	ADJ	B
association	O	NOUN	B
and	O	CCONJ	O
replication	O	NOUN	B
asynchrony	O	NOUN	B
are	O	AUX	O
not	O	PART	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
imprinting	O	NOUN	B
mechanism	O	NOUN	B
.	O	PUNCT	O


Linkage	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
5	O	NUM	O
novel	O	ADJ	B
van	B-Disease	X	B
der	I-Disease	NOUN	I
Woude	I-Disease	NOUN	I
syndrome	I-Disease	NOUN	I
kindreds	O	NOUN	B
to	O	PART	O
1q32	O	NOUN	B
-	O	PUNCT	O
q41	O	NOUN	B
markers	O	NOUN	B
further	O	ADV	O
supports	O	VERB	O
locus	O	NOUN	B
homogeneity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
trait	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
vWS	B-Disease	NOUN	B
gene	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
assigned	O	VERB	O
to	O	PART	O
a	O	DET	O
locus	O	NOUN	B
in	O	ADP	O
1q32	O	NOUN	B
-	O	PUNCT	O
q41	O	NOUN	B
by	O	ADP	O
linkage	O	NOUN	B
analysis	O	NOUN	I
and	O	CCONJ	O
physical	O	ADJ	B
mapping	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	B
support	O	VERB	O
linkage	O	NOUN	B
of	O	ADP	O
vWS	B-Disease	NOUN	B
within	O	ADP	O
a	O	DET	O
region	O	NOUN	B
of	O	ADP	O
tightly	O	ADV	O
linked	O	VERB	O
markers	O	NOUN	B
and	O	CCONJ	O
do	O	AUX	O
not	O	PART	O
favour	O	VERB	O
locus	O	NOUN	B
heterogeneity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
disease	O	NOUN	B
trait	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
homologous	O	ADJ	B
recombination	O	NOUN	I
to	O	PART	O
disrupt	O	VERB	B
the	O	DET	O
normal	O	ADJ	B
translation	O	NOUN	B
of	O	ADP	O
ATP7B	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
generated	O	VERB	O
a	O	DET	O
strain	O	NOUN	B
of	O	ADP	O
mice	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
homozygous	O	ADJ	B
mutants	O	NOUN	B
(	O	PUNCT	O
null	O	NOUN	B
)	O	PUNCT	O
for	O	ADP	O
the	O	DET	O
Wilson	B-Disease	NOUN	B
disease	I-Disease	NOUN	I
gene	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
increase	O	NOUN	B
in	O	ADP	O
copper	O	NOUN	B
concentration	O	NOUN	B
was	O	AUX	O
also	O	ADV	O
observed	O	VERB	O
in	O	ADP	O
the	O	DET	O
kidney	O	NOUN	B
,	O	PUNCT	O
brain	O	NOUN	B
,	O	PUNCT	O
placenta	O	NOUN	B
and	O	CCONJ	O
lactating	O	VERB	B
mammary	O	ADJ	B
glands	O	NOUN	I
of	O	ADP	O
homo	O	ADJ	B
-	O	PUNCT	O
zygous	O	NOUN	B
mutants	O	NOUN	B
,	O	PUNCT	O
although	O	SCONJ	O
milk	O	NOUN	B
from	O	ADP	O
the	O	DET	O
mutant	O	ADJ	B
glands	O	NOUN	I
was	O	AUX	O
copper	B-Disease	NOUN	B
deficient	I-Disease	ADJ	B
.	O	PUNCT	O


Progeny	O	NOUN	B
of	O	ADP	O
the	O	DET	O
homozygous	O	ADJ	B
mutant	O	ADJ	B
females	O	NOUN	B
demonstrated	O	VERB	O
neurological	B-Disease	ADJ	B
abnormalities	I-Disease	NOUN	I
and	O	CCONJ	O
growth	B-Disease	NOUN	B
retardation	I-Disease	NOUN	I
characteristic	O	NOUN	O
of	O	ADP	O
copper	B-Disease	NOUN	B
deficiency	I-Disease	NOUN	I
.	O	PUNCT	O


Segregation	O	NOUN	B
distortion	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
reported	O	VERB	O
to	O	PART	O
occur	O	VERB	O
in	O	ADP	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
the	O	DET	O
trinucleotide	B-Disease	NOUN	B
repeat	I-Disease	NOUN	I
disorders	I-Disease	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
a	O	DET	O
sperm	O	NOUN	B
typing	O	NOUN	I
study	O	NOUN	B
performed	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
of	O	ADP	O
Japanese	O	ADJ	B
descent	O	NOUN	B
with	O	ADP	O
Machado	B-Disease	PROPN	B
-	I-Disease	PUNCT	O
Joseph	I-Disease	PROPN	B
disease	I-Disease	NOUN	I
(	O	PUNCT	O
MJD	B-Disease	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
it	O	PRON	O
was	O	AUX	O
reported	O	VERB	O
that	O	SCONJ	O
disease	O	NOUN	B
alleles	O	NOUN	I
are	O	AUX	O
preferentially	O	ADV	O
transmitted	O	VERB	B
during	O	ADP	O
meiosis	O	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
analysis	O	NOUN	B
of	O	ADP	O
the	O	DET	O
variance	O	NOUN	B
in	O	ADP	O
repeat	O	NOUN	O
number	O	NOUN	O
in	O	ADP	O
sperm	O	NOUN	B
from	O	ADP	O
the	O	DET	O
French	O	ADJ	B
MJD	B-Disease	NOUN	B
patients	O	NOUN	B
overlapped	O	VERB	B
significantly	O	ADV	B
with	O	ADP	I
the	O	DET	O
variance	O	NOUN	B
in	O	ADP	O
repeat	O	NOUN	O
number	O	NOUN	O
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
C	O	PROPN	B
/	O	PUNCT	O
C	O	NOUN	B
homozygous	O	ADJ	B
Japanese	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
ascertained	O	VERB	O
a	O	DET	O
novel	O	ADJ	O
missense	O	NOUN	B
mutation	O	NOUN	I
in	O	ADP	O
four	O	NUM	O
pedigrees	O	NOUN	B
with	O	ADP	O
Peters	B-Disease	PROPN	B
anomaly	I-Disease	NOUN	I
,	O	PUNCT	O
congenital	B-Disease	ADJ	B
cataract	I-Disease	NOUN	I
,	O	PUNCT	O
Axenfeldt	B-Disease	PROPN	B
anomaly	I-Disease	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
/	O	SYM	O
or	O	CCONJ	O
foveal	B-Disease	ADJ	B
hypoplasia	I-Disease	NOUN	I
,	O	PUNCT	O
which	O	DET	O
,	O	PUNCT	O
to	O	PART	O
our	O	PRON	O
knowledge	O	NOUN	B
,	O	PUNCT	O
is	O	AUX	O
the	O	DET	O
first	O	ADJ	O
mutation	O	NOUN	B
identified	O	VERB	B
in	O	ADP	O
the	O	DET	O
splice	O	NOUN	B
-	O	PUNCT	O
variant	O	ADJ	B
region	O	NOUN	B
.	O	PUNCT	O


Penetrances	O	NOUN	B
of	O	ADP	O
BRCA1	O	NOUN	B
1675delA	O	NOUN	B
and	O	CCONJ	O
1135insA	O	NOUN	B
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
breast	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
and	O	CCONJ	O
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Index	O	NOUN	O
cases	O	NOUN	B
for	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
were	O	AUX	O
found	O	VERB	O
two	O	NUM	O
different	O	ADJ	O
ways	O	NOUN	O
through	O	ADP	O
a	O	DET	O
series	O	NOUN	O
of	O	ADP	O
consecutive	O	ADJ	B
ovarian	B-Disease	ADJ	B
cancers	I-Disease	NOUN	I
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
16	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
through	O	ADP	O
our	O	PRON	O
family	O	NOUN	B
cancer	B-Disease	NOUN	I
clinic	O	NOUN	I
(	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
14	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
overall	O	ADJ	O
findings	O	NOUN	B
were	O	AUX	O
that	O	SCONJ	O
disease	O	NOUN	B
started	O	VERB	O
to	O	PART	O
occur	O	VERB	O
at	O	ADP	O
age	O	NOUN	B
30	O	NUM	O
years	O	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
by	O	ADP	O
age	O	NOUN	B
50	O	NUM	O
years	O	NOUN	B
48	O	NUM	O
%	O	NOUN	O
of	O	ADP	O
the	O	DET	O
mutation	O	NOUN	B
-	O	PUNCT	O
carrying	O	VERB	B
women	O	NOUN	B
had	O	AUX	O
experienced	O	VERB	O
breast	B-Disease	NOUN	B
and	I-Disease	CCONJ	O
/	I-Disease	SYM	O
or	I-Disease	CCONJ	O
ovarian	I-Disease	ADJ	B
cancer	I-Disease	NOUN	I
.	O	PUNCT	O


Both	O	CCONJ	O
penetrance	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
(	O	PUNCT	O
breast	B-Disease	NOUN	B
cancer	I-Disease	NOUN	I
vs	O	CCONJ	O
.	O	PUNCT	O
ovarian	B-Disease	ADJ	B
cancer	I-Disease	NOUN	I
)	O	PUNCT	O
were	O	AUX	O
different	O	ADJ	O
from	O	ADP	O
those	O	DET	O
in	O	ADP	O
reports	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ashkenazi	O	PROPN	B
founder	O	NOUN	I
mutations	O	NOUN	B
.	O	PUNCT	O


